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Subject: Evaluation of Amit Kumar Rai's thesis 
 
 
To whom it may concern, 
 
 
In his thesis manuscript, Amit Kumar Rai presents the results he has obtained on 
the ectopic ATP-synthase. Using electrophoresis techniques coupled to mass 
spectrometry analyses, he was able to demonstrate that the enzyme found in plasma 
membranes was active and contained both nuclear and mitochondrially encoded proteins, 
thus indicating that the ectopic enzyme is probably imported from mitochondria rather 
than being assembled in the plasma membrane. The apparent molecular weight of the 
ectopic ATP-synthase is similar to the monomeric mitochondrial ATP-synthase complex. 
Only monomeric forms of ATP-synthase were found in plasma membranes, in contrast to 
the mitochondrial enzyme where it can be found as oligomeric species. Two methods of 
plasma membrane preparation were used and compared, the second one leading to more 
active ectopic ATP-synthases. The dependency to temperature of ATP-synthase 
extraction clearly excluded that the data obtained were not due to an artifact of 
contamination of plasma membranes with mitochondrial membranes. 
By immuno-fluorescence studies, Amit Kumar Rai has shown that, in the 
membranes of HeLa cells, antibodies against the β-subunit and the inhibitor IF1 co-
localized with antibodies directed against flotillin, a marker of lipid raft domains. 
Furthermore, he has demonstrated that the ectopic ATP-synthase was present in 
membrane sub-fractions corresponding to basolateral membrane fractions of hepatocytes.  
 
Two very interesting results have been obtained. Amit Kumar Rai has found that 
the relocation of the β-subunit and the IF1 inhibitor to the plasma membrane was 
enhanced by cholesterol and that the ratio IF1/β in the plasma membrane was also 
increased. This higher IF1 content could prevent any depletion of ATP at the cell surface. 
Using a home-made set up, Amit Kumar Rai was also able to measure an ATP-synthase 
activity at cell surface and this finding will open the door to many new experiments.  
 Amit Kumar Rai has used varied approaches and a large scale of techniques. The results 
obtained in his thesis are extremely important to understand the role of the ectopic ATP-
synthase.  
The manuscript is carefully written with a very detailed and well-documented 
introduction. The figures are very clear and experiments in Material and Methods are well 
described.  
 
For all the reasons above-mentioned, I can only give a favourable answer to the doctoral 
thesis defence of Amit Kumar Rai. 
 
Sincerely,  
 
Marie-France Giraud. 
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Doctoral (PhD) School of Pharmacological Sciences 
Judgment on overall research activities of Dott. AMIT KUMAR RAI 
Committee of the Doctoral (PhD) School of Pharmacological Sciences, 
Molecular and cellular Pharmacology Section of 11/28/2012 
Dr. Amit Kumar Rai carried out his research required by the Graduate School in 
Pharmacological Sciences, Molecular and Cellular Pharmacology (XXV cycle), at the 
Department of Pharmaceutical and Pharmacological Sciences, University of Padova and 
partly at Department of Food Science and Technology, University of Udine and 
Department of Veterinary Basic Sciences, Royal Veterinary College, University of 
London, UK. 
The research carried out by Dr. Rai was focused on the characterization of ectopic F0F1 
ATP synthase from plasma membrane of rat liver with reference to its role in mediating 
HDL endocytosis. The work was based on the previous research paper published by Prof. 
Lippe et al. in 2010 highlighting the role of inhibitory factor IF1 in modulating the 
activity of ectopic F0F1 ATP synthase in acute cholestasis. Interesting findings from the 
literature highlighted other roles of ectopic enzyme in tumor recognition, cell 
proliferation, angiostatin receptor, pH maintenance at extracellular level but nothing had 
been discussed about the subunit composition and characterization of this enzyme which 
was important in understanding better its role in various pathological conditions. Based 
on this we decided to isolate and characterized the ectopic F0F1 ATP synthase from rat 
liver plasma membranes using different proteomic approaches.  
In the first year of the PhD. Dr. Rai got hands-on experience in preparation of 
mitochondria from rat liver, detergent extraction of the native enzyme, preparation of 
gradient native gel and Blue Native Electrophoresis, SDS PAGE and in-gel activity 
staining of all the OXPHOS complexes. Based on these experiences he established the 
method to prepare plasma membrane fractions from rat liver followed by the detergent 
extraction of the enzyme using various nonionic detergents such as dodecylmaltoside, 
digitonin and Triton X100. In addition, he established the method of hr CN PAGE for the 
in-gel staining of OXPHOS complexes isolated from both mitochondria and plasma 
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membrane fractions. During this period he gave an oral presentation on “The effect of 
detergents on the stability of ectopic F0F1 complex from plasma membrane” in the annual 
meeting of GIBB 2010 in Bertinoro and in the same year he presented a poster on 
“Ectopic F0F1 ATP Synthase from rat liver: structural and proteomic characterization” in 
European Bioenergetics Conference in Warsaw, Poland. Besides this major project, Dr. 
Rai was involved in other projects in the lab of Dr. G. Lippe, Univ. of Udine, in 
deciphering the interaction of cyclophillin-D with ATP synthase. 
In the second year of his research he conducted a similar set of experiments to 
characterize the ectopic enzyme from HUVEC and osteosarcoma cells. A major 
breakthrough was achieved after he established a new method to prepare pure plasma 
membrane sheets from rat liver. This new method improved over the previous one, as it 
yielded a complete and highly active form of ectopic F0F1 ATP synthase as demonstrated 
by in-gel activity staining and native immunoblotting. In order to understand the subunit 
composition of the holo-complex, the enzyme was extracted from gel bands of hr CN 
PAGE and was subjected to mass analysis in collaboration with CRIBI, University of 
Padova. Dr. Rai also gave a talk on “Effect of plasma membrane micro-domains on the 
composition of ectopic F0F1 ATP synthase” in the annual meeting of GIBB 2011 held at 
Sapienza University in Rome. 
By the end of second year he started to work in the lab of Dr. M. Campanella at the RVC, 
University of London UK for 6 months. In that period he established the method of cell 
fractionation to prepare mitochondrial and plasma membrane fractions for the 
characterization of the ectopic enzyme. He also conducted confocal microscopy studies 
on the co-localisation of subunits of F0F1 ATP synthase such as β subunit, OSCP, IF1 
with a lipid raft maker flotillin providing a visual proof of the expression of these proteins 
at the cell surface. He studied as well the role of cholesterol in mediating the trafficking 
of these subunits from mitochondria to plasma membrane by means of cholesterol 
loading experiments performed on HeLa cells using immunofluorescence and western 
blotting.  
To explore in greater depth the presence of whole F0F1 complex in plasma membrane, Dr. 
Rai conducted immunoprecipitation of the whole complex along with its subunits under 
the supervision of Dr. G. Lippe at University of Udine. He also conducted lipid analyses 
of the mitochondrial and plasma membrane fractions using 2d TLC to check purity of the 
preparations. Based on the above experiments he was able to conclude that ectopic F0F1 
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ATP synthase exists as the whole complex with the same subunit composition and similar 
molecular weight to that of mitochondrial entity. By the end of the third year he separated 
basolateral and apical membranes from plasma membrane to determine the exact 
localization of the ectopic F0F1 ATP synthase, from where it mediates the HDL 
endocytosis. During his last year he presented an oral presentation on his work in GIBB 
2012, University of Calabria and EBEC 2012, University of Freiburg, Germany along 
with two poster presentations in EBEC 2012.  
In these three years of his PhD Dr. Amit Kumar Rai has carried out its research activities 
with perseverance and determination, applying with commitment to all aspects of 
laboratory activities. Participation in the national and international conferences has 
enabled him to develop good presentation skills required. The year spent at the RVC, 
University of London also allowed him to interact and work with a professional research 
group which helped him in gaining confidence in designing and conducting his own 
experiments. 
The Board, therefore, expresses its unanimously favorable opinion on the dissertation of 
the candidate with the title: "Proteomic and immune-fluorescence studies of Ectopic 
F0F1 ATP synthase-a novel pharmacological target of HDL endocytosis in liver" 
 
 
 
                   THE SECRETARY                                                 THE DIRECTOR 
                Dr. Monical Montopoli                                               Prof. Pietro Guisti 
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SCUOLA DI DOTTORATO IN SCIENZE FARMACOLOGICHE  
Giudizio sull‟ attività Complessiva svolta dal Dott. AMIT KUMAR RAI 
Collegio Docenti della Scuola di Dottorato in Scienze Farmacologiche 
Indirizzo in Farmacologia Molecolare e Cellulare del 28/11/2012 
Il Dr. Amit Kumar Rai ha svolto la sua ricerca richiesta dalla Scuola di Dottorato in 
Scienze Farmacologiche, Indirizzo in Farmacologia Molecolare e Cellulare (XXV ciclo), 
per buona parte presso il Dipartimento di Scienze del Farmaco (sede ex Farmacologia, 
Largo E. Meneghetti, 2), Università di Padova. Parte della ricerca è stata svolta presso il 
Dipartimento di Scienze e Tecnologie Alimentari, Università di Udine e Dipartimento di 
Veterinaria Scienze di base, Royal Veterinary College, Università di Londra, Regno 
Unito. 
La ricerca condotta dal Dr. Rai si è concentrata sulla caratterizzazione di F0F1 ATP 
sintasi ectopica presente sulla membrana plasmatica di fegato di ratto. Tale enzima ha un 
importante ruolo nella endocitosi di HDL. Il lavoro approfondisce una ricerca pubblicata 
dal gruppo Lippe et al. 2010, che ha evendiziato il ruolo di IF1, fattore inhibitorio e 
modulatore dell‟attività di ectoF0F1 ATP sintetasi, nella colestasi acuta. In letteratura 
inoltre sono stati evendiziati altri ruoli di ecto ATP sintetasi per la proliferazione 
cellulare, il legame di angiostatina e il mantenimento del pH a livello extracellulare.scarse 
sono le indagini che riguardano la caratterizzazione dell‟enzima, la composizione delle 
sue subunità, e il suo ruolo nelle varie condizioni fisio- patologiche. 
Partendo da questa analisi si e deciso di isolare e caratterizzare ecto F0F1 ATP sintasi da 
membrane plasmatiche di fegato di ratto utilizzando diversi approcci proteomici 
Nel primo anno del Dottorato il Dr. Rai ha fatto esperienza nella preparazione dei 
mitocondri di fegato di ratto, nell‟estrazione detergente di enzimi nativi, nella 
preparazione di gel elettroforesi nativa (Blue- Native) su gradiente, SDS PAGE e 
colorazione in gel di attività di tutti i complessi OXPHOS. Sulla base di queste esperienze 
egli ha messo a punto il metodo per la preparare di frazioni di membrana plasmatica di 
fegato di ratto seguita dalla estrazione di ecto ATP sintetasi nativa utilizzando vari 
  
 
detergenti non ionici come DodecylMaltoside, Digitonina e Triton X100. Oltre a questo 
ha messo a punto il metodo elettroforetico CN PAGE piu adatto della BN PAGE per la 
colorazione nativa in gel di complessi OXPHOS isolati sia da mitocondri che da 
membrana plasmatica. Alla fine del primo anno ha presentato i risultati su "L'effetto dei 
detergenti sulla stabilità del complesso F0F1 ectopica della membrana plasmatica" nella 
riunione annuale dei GIBB 2010 a Bertinoro e il mese successivo ha presentato un poster 
sullo stesso argomento alla Conferenza Europea di Bioenergetica (EBEC 2010) tenutassi 
a Varsavia, Polonia. Il dr. Rai approfondire le techniche di proteomica, è stato coinvolto 
in alcuni progetti nel laboratoro del Dr. G. Lippe, Unv. Di Udine, riguardanti 
I‟interazione di cyclophillin- D con I‟ ATP sintetasi mitochondriale. 
Nel 2 ° anno della sua ricerca il dott. Rai ha compiuto esperimenti simili a quelli fatti nel 
primo anno per caratterizzare I‟enzima ectopio di cellule primarie (HUVEC) e cellule di 
osteosarcoma. Un importante passo avanti è stato raggiunto dopo che egli ha egli ha 
sperimentato un nuovo metedo per la preparazione di membrane plasmatica di fegato di 
ratto arricchite di ecto ATP sintetasi. Questo nuovo metodo è migliore di quell 
tradizionale precedentemente usato in quanto ha prodotto una forma integra e attiva di 
F0F1 ATP sintasi ectopica come dimostra con colorazione in CN PAGE e 
immunoblotting. Al fine di comprendere la composizione delle subunità, I‟olo-complesso 
è stato estratto da bande di CN PAGE e sottoposto all'analisi di massa presso il “CRIBI” 
dell‟ Università degli Studi di Padova. Durante questo secondo anno il Dr. Rai anche 
presentato una communicazione orale sul tema "Influenza dei micro-domini della 
membrana plasmatica sulla composizione della ATP sintasi ectopica " in occasione della 
riunione annuale del GIBB 2011 presso Sapienza Università di Roma. 
Alla fine del 2°  e inizio del 3° anno di dottorato il Dr. Rai ha lavorato nel laboratorio del 
Dr. M. Campanella presso la, RVC Università di Londra UK, dove è rimasto per sei mesi. 
In tale periodo ha messo a punti il metodo di frazionamento cellulare per preparare 
mitocondri e membrane plasmatiche, necessarie queste ultime per la caratterizzazione 
della ecto ATP syntetasi. A Londra ha condotto anche studi di microscopia confocale per 
stabilire la co-localizzazione di subunità di ectoF0F1 ATP sintasi quali le subunità β, 
OSCP, IF1 con la flotillina, proteina localizzata nei “lipid rafts”, che fornise quindi una 
prova visiva della espressione di ecto ATP sintetasi sulla superficie cellulare. Nel 
Laboratio del dr Campanella egli ha inoltre studiato il ruolo del colesterolo nel mediare il 
transferimento delle subunità dell enzima dai mitocondri alla membrana plasmatica 
  
 
facendo esperimenti di carico di colesterolo condotti su cellule HeLa anilazzate poi con 
techniche di immunofluorescenza e western blotting. Per approfondire ulteriormente 
l'argomento per quanto riguarda la presenza di tutta F0F1 complesso nella membrana 
plasmatica, il dottor Rai ha condotto immunoprecipitazione del complesso intero e di 
differenti sub-unità presso l'Università degli Studi di Udine sotto la supervisione del Dr. 
G. Lippe. Per verificare la purezza delle preparazioni il dr. Rai ha anche fatto I‟ analisi 
dei fosfolipidi delle frazioni di membrana mitocondriale e di membrane plasmatiche 
utilizzando il metodo 2D-TLC Infine, sulla base delle esperienze di cui sopra il dr. Rai e 
stato in grado di concludere che ectopica F0F1 ATP sintetasi esiste come complesso sulla 
membrana plasmatica e che il peso molecolare e la composizione in subunità è simile 
della proteina mitocondriale. Alla fine del terzo anno il suo compito e‟ stato quello di 
separare le membrane apicali e basolaterali del epatocita per determinare l‟esatta 
localizzazione della ecto F0F1 ATP sintetasi ,enzima che media l‟ endocitosi HDL e 
quindi enzima strategico nel RCT.  
Anche nell‟ ultimo anno egli ha presentato i suoi risultati come presentazione orale in 
GIBB 2012, presso l‟Università della Calabria e al Congresso Europeo di Bioenergetica 
(„EBEC 2012)  presso l‟ Università di Friburgo, in Germania dove ha presentato due 
poster e fatto una communicazione orale. 
 In questi tre anni di dottorato di ricerca il dottor Amit Kumar Rai ha svolto la propria 
attività di ricerca con perseveranza e determinazione, applicandosi con impegno per lo 
svolgimento del laboratorio e mostrando interesse per le varie attività. La partecipazione 
ai convegni nazionali ed internazionali gli ha permesso di sviluppare una buona capacità 
di presentazione necessarie per la discussione dei risultati. I sei messe di lavoro la RVC 
Università di Londra aveva gli hanno permesso di interagire e lavorare con un gruppo di 
ricerca molto competento e lo hanno aiutato a conquistare la fiducia nel progettare e 
condurre i suoi esperimenti. 
 
 
 
 
 
  
 
Il Consiglio, pertanto, esprime all'unanimità parere favorevole alla tesi che il candidato 
presenterà in sede di Esame Finale, dal titolo: “Proteomic and immune-fluorescence 
studies of Ectopic F0F1 ATP synthase a novel pharmacological target of HDL 
endocytosis in liver” 
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Abstract  
Over the past few years, several reports have described the presence of F0F1 ATP 
synthase subunits and it’s inhibitor IF1 at the cell surface of various cells with the catalytic F1 
sector facing outside. The enzyme, called ectopic ATPase/synthase, was found to mediate 
various biological functions such as HDL endocytosis, transmembrane pH regulation, tumor 
cell recognition. An intriguing question is whether the ectopic enzyme has the same subunit 
composition and molecular mass as that of the mitochondrial ATP synthase. Another 
question is its localization in plasma membrane, especially in hepatocytes due to their polar 
nature, where the enzyme mediates HDL endocytosis. Using different methods to prepare rat 
liver plasma membranes, which have been subjected to digitonin extraction, hr CNE, 
immunoblotting, immunoprecipitation and mass spectrometry, the presence of ectopic F0F1 
complexes with a similar molecular weight to the monomeric form of the mitochondrial 
complexes was demonstrated. Moreover, these complexes contained both nuclear and 
mitochondrially-encoded subunits, making it unlikely that the enzyme is assembled on the 
plasma membranes, while suggesting it to be transported after being assembled in 
mitochondria by still unknown pathways. Moreover, the plasma membrane preparation 
enriched in basolateral proteins contained much higher amounts of complete and active F0F1 
complexes, suggesting their localization on this cellular pole, which was consistent with their 
specific function to modulate HDL uptake on hepatocyte surface. 
Immunofluorescence studies allowed to demonstrate that the ecto-F0F1 complexes 
were localized in lipid rafts of plasma membrane on the HeLa cells. Only in non-
permeabilized cells IF1 co-localized with the F0F1 ATP synthase β-subunit and flotillin, a 
lipid raft marker. In accordance, the OSCP subunit (oligomycin sensitivity conferring 
protein) was also found to pair with the β-subunit and IF1, suggesting the presence of a 
functional–although small mitochondria-like organization on the cell surface of HeLa cells. 
Notably, cholesterol loading in HeLa cells, performed at different time intervals, reduced the 
mitochondrial content of IF1, with a parallel increase of its ectopic expression. The higher 
surface expression of IF1 could therefore represent a mechanism to preserve ATP level on the 
extra cellular space sparing this from the F0F1 ATPase mediated hydrolysis. 
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In conclusion, our studies both at tissue and cellular level demonstrate the existence of 
complete and functional ectopic F0F1 ATP synthase displaying a similar molecular weight as 
that of mitochondrial complex. 
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1. Introduction 
1.1 Mitochondria  
Mitochondria are cytoplasmic organelles of variable size, with a diameter between 0.5 
and 5 μm, responsible of the aerobic production of ATP by the oxidative phosphorylation 
system (OXPHOS). They also participate in intermediary metabolism of lipids, nucleotides, 
heme and urea and are involved in the early stages of cell death (Osellame et al., 2012). 
These organelles, which are present only in the cytoplasm of eukaryotic cells, may vary 
greatly in terms of number and size, depending on the cell type. Their number varies from a 
few hundred to several thousand in more metabolically active cells, such as liver, where they 
occupy 15-20% of the cell volume (Karp, 2008). 
Mitochondria are bounded by two membranes, the inner (IMM) and outer (OMM) 
membrane. The aqueous region between the two membranes is called intermembrane space 
(IMS) (Figure 1.1). The inner membrane delimits the matrix space and has many 
invaginations, called cristae, which are connected to the IMS by cristae junctions (Mannella, 
2000). While the first electron microscopy (EM) images suggested that mitochondria were 
separate entities floating freely in the cytoplasm, the use of specifically addressing 
recombinant probes definitely demonstrated that within living cells they form a dynamic 
network (Rizzuto et al., 1998), which is subject to ongoing arrangements by the fusion and 
fission machinery (Westermann, 2008). Moreover, they continuously move along 
cytoskeletal tracks and are in close association with membranes of the endoplasmic reticulum 
(Figure 1.1) (Mannella, 2000;  Rutter and Rizzuto, 2000). Mitochondrial shape and 
positioning in cells is crucial for cellular metabolism and is tightly regulated by processes of 
fission and fusion, ensuring a relatively constant mitochondrial population  (Osellame et al., 
2012).  
 The inner membrane accommodates large numbers of the five complexes of the 
OXPHOS (complexes I-V). The complexes I to IV are oxidoreductases which, with the 
exception of complex II, couple electron transport with translocation of protons across the 
inner membrane. The generated proton motive force drives much of mitochondrial 
physiology – the synthesis of adenosine triphosphate (ATP) by ATP synthase (complex V), 
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the transfer of calcium and other ion exchangers, and the import of proteins (Osellame et al., 
2012). 
 
 
Figure 1.1 Mitochondrion from rat liver surrounded by the endoplasmic reticulum. EM image is 
reproduced from (Mannella, 2000). ER is in violet, OMM in red, IMM in blue, cristae are in green and rRNA in 
yellow.  
Complex I or NADH dehydrogenase is the first and major entrance point of electrons 
to the respiratory chain. It transfers electrons from NADH molecules to a lipophilic quinone 
designated ubiquinone (Q10). Complex II or succinate dehydrogenase transfers electrons 
from succinate to ubiquinone and directly connects the citric acid cycle to the respiratory 
chain. From reduced ubiquinone electrons are transferred to complex III or cytochrome c 
reductase which exists in the membrane as a functional dimer. The small protein cytochrome 
c mediates electron transfer from cytochrome c reductase to cytochrome c oxidase (complex 
IV). Finally, electrons are transferred to molecular oxygen which is reduced to water (Figure 
1.2). 
 
Figure 1.2 Schematic representation of the OXPHOS system. This figure showing individual components of 
the OXPHOS  system. The position of the matrix (M), the intermembrane space (IMS) and cristae or inner 
membrane (IMM) has been indicated (Osellame et al., 2012). 
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The IMM also contains many transporters or carriers that translocate nucleotides, 
inorganic ions and metabolites, including phosphate, thereby determining the 
compartmentalization of the metabolic functions of mitochondria. Globally, mitochondria 
contain 800 (yeast) to 1500 (human) different proteins. Although the majority of 
mitochondrial proteins are encoded in the nucleus and post-translationally imported into the 
organelle by a complex protein-import machinery (Baker et al., 2007), some subunits of the 
OXPHOS (13 in human) are encoded by the mitochondrial genome (mtDNA). This is a 
circular double-stranded molecule of approximately 16.5 kb without introns and histone 
proteins, which also encodes rRNA and tRNA. On an average, mtDNA is present in two 
copies per organelle and is almost exclusively maternally inherited. 
Defects in mitochondrial DNA (mtDNA) have been associated with the mitochondrial 
diseases, which encompass a wide variety of degenerative diseases, aging, and cancer 
(Wallace, 2007). Deficiencies in OXPHOS appear to be the main pathogenic factors, 
although other mechanisms are involved, such as generation of reactive oxygen species 
(ROS) by the respiratory complexes and/or altered apoptotic signaling that are implicated in 
neurodegenerative diseases (McKenzie et al., 2004) (see also section 1.2.5). 
1.2 Mitochondrial F0F1 ATP synthase 
The mitochondrial ATP synthase, also named F0F1 ATP synthase or complex V, is a 
600 kDa multisubunit complex localized in the IMM that uses the energy contained in the 
transmembrane proton gradient to drive the synthesis of ATP from ADP to Pi. Traditionally, 
ATP synthase is divided into two subcomplexes, the membrane-embedded F0 subcomplex 
through which the protons flow, and the peripheral F1 subcomplex that carries the nucleotide 
binding sites (Figure 1.3). Its molecular structure and catalytic mechanism were understood 
by the seminal work of the Nobel Laureates Mitchell (in 1979), Boyer and Walker (in 1997) 
that revealed its complexity and the functional steps driving the synthesis of ATP.  
In addition to the IMM, ATP synthase is present in the thylakoid membrane of 
chloroplasts, and in the plasma membrane of bacteria, and it is well conserved considering its 
structural complexity and the early divergence of bacteria, plants and animals (Nelson, 
1992). Proton translocation and ATP synthesis are coupled by a unique mechanism, subunit 
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rotation, and ATP synthase is a miniature engine also called nano-motor. The 
electrochemical energy contained in the proton gradient is converted into mechanical energy 
in form of subunit rotation and back into chemical energy as ATP (Capaldi and Aggeler, 
2002;  Stock et al., 2000;  Weber and Senior, 2003). The enzyme is also able to work in the 
direction of ATP hydrolysis, sustaining the formation of the proton gradient, when there is 
loss of membrane potential.  
 
Figure 1.3 Schematic representation of bacterial (A) and mitochondrial F0F1 ATP synthases (B). In the 
bacterial enzyme the F1 subcomplex is assembled with a stoichiometry of 33δε and the F0 subcomplex with a 
stoichiometry of ab2c10-14. In eukaryotes the F0 part contains the additional subunits OSCP, b, e, f, g, A6L with a 
c-ring formed by 8-10 subunits. 
In the simplest form of the enzyme, in bacteria like Escherichia coli, F0 consists of 
three different subunits, a, b and c, with relative molecular masses 30.3, 17.2 and 8.3 kDa 
respectively and stoichiometry ab2c9-12 (Walker et al., 1984). Chloroplast and cyanobacteria 
F0 are composed of four subunits due to the fact that the two b subunits are not identical 
(Fromme et al., 1987). The animal mitochondrial enzyme has a more complicated structure 
since ten subunits have been identified, a, b, c, F6, d, e, A6L, f, g and oligomycin sensitivity 
conferring protein (OSCP) (Collinson et al., 1994). The a, b and c subunits share great 
similarity with the bacterial subunits, OSCP is analogous to E.coli δ-subunit, whereas the 
remaining subunits are unique of the mitochondrial complex. Besides these subunits, in some 
mammals such as beef, rat and man two hydrophobic proteins namely MLQ/6.8-kDa 
mitochondrial proteolipid (Chen et al., 2007;  Meyer et al., 2007), and AGP/DAPIT (diabetes 
associated protein in insulin sensitive tissue) (Ohsakaya et al., 2011) are associated to the F0 
part when phospholipids are not extracted. It has been shown recently that DAPIT has a role 
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in maintaining ATP synthase amount in mitochondria and therefore possibly can influence 
cellular energy metabolism (Jonckheere et al., 2012). All together, the mitochondrial 
membrane domain is constituted by approximately 30 trans-membrane α-helices (Carroll et 
al., 2009).  
The structure of the F1 complex results highly conserved. In all cases it is composed 
of five different subunits, α through ε, with stoichiometry α3β3γδε (Walker et al., 1985;  
Walker et al., 1984). In the F1 sector always the α- and β-subunits are arranged alternatively, 
forming a hexagonal cylinder around the coiled-coil structure of the γ subunit. In fact, the α, 
β and γ subunits from different sources are highly conserved sharing high degree of sequence 
identity. Conversely, the small δ and ε subunits are not analogous in enzymes of different 
origin; bacterial and chloroplast δ and ε correspond to OSCP and δ subunit respectively of 
the mitochondrial ATP synthase, while the ε subunit of the mitochondrial complex has no 
counterpart in the bacterial enzyme (Walker and Collinson, 1994;  Walker et al., 1991). In 
addition, the mitochondrial complex can bind the inhibitor protein IF1, which reversibly 
binds to F1 with a 1:1 stoichiometry and fully inhibits the enzyme activity (Bason et al., 
2011;  Harris and Das, 1991). 
Despite differences among complexes of different origin, the mechanism of active 
proton transport and ATP synthesis/hydrolysis is highly conserved, as supported by the use 
of mitochondrial and chloroplast subunits as functional replacement in the bacterial 
complexes (Lill et al., 1993;  Puri et al., 2005;  Richter et al., 2000).  
The extramembranous F1 complex and the F0 complex are linked by central and 
peripheral stalks (Gibbons et al., 2000;  Rubinstein et al., 2005;  Rubinstein et al., 2003). The 
F0 rotor consists of a ring of c-subunits that is associated with the central stalk made of the 
three F1 subunits γ,δ and ε. Proton-power rotation of the c-ring with associated central stalk 
proteins generates torque and conformational changes in the catalytic α3β3  domain of the F1-
part to synthesize ATP (Noji et al., 1997;  Sabbert et al., 1996;  Seelert et al., 2000). The α3β3 
ring contains the three catalytic nucleotide binding sites, on the β subunits at the interface to 
the adjacent α subunit. α3β3 are held together by the “peripheral stalk” comprising the 
subunits b, d, F6 and OSCP (or “stator stalk”), of which the crystal structure of the soluble 
part (b,dF6sol) (Walker and Dickson, 2006) and in complex with F1 (Rees et al., 2009) has 
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been obtained in bovine. The enzyme mechanism is called rotary catalysis (Figure 1.4A). In 
a sudden loss of membrane potential due to leakage of protons back in to the matrix or in 
some conditions like ischemia, the enzyme functions in the direction of ATP hydrolysis 
sustaining the formation of proton gradient and maintaining the membrane potential  (Figure 
1.4B). F0F1 is an unusually efficient rotary motor that synthesizes ATP at rates exceeding 100 
molecules per second (Senior, 2007). 
 
Figure 1.4 Schematic representation of ATP synthesis and hydrolysis by F0F1 ATP synthase.  
(A) Flow of protons through F0 leads to the rotation of c rings with central stalk which in-turn leads to the 
rotation of δε leading to synthesis of ATP from ADP in a  subunit of F1.  
(B) The hydrolysis is mediated by flow of protons in opposite direction leading to the rotation of central stalk 
and c rings in opposite direction. 
The subunit composition of the ATP synthase from prokaryotic and eukaryotic sources along 
with the subunit homology and the corresponding nomenclature is reported in Table 1.  
1.2.1 The rotary mechanism of F0F1 ATP synthase 
Numerous atomic models of various conformations of the mitochondrial F1 part 
established that the three β-subunits adopt three different tertiary structures and are in three 
diverse nucleotide-bound states. According to the original paper published at the beginning 
of the Nineties (Abrahams et al., 1994) two of them have similar conformations, but one, 
designated βTP, hosts the binding site for ATP and the second, called βDP, binds with high 
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affinity ADP and Pi. The third, βE, has adopted a radically different conformation in which 
the nucleotide binding domain is disrupted and has no bound nucleotide.  
 Stoichiometry Prokaryotes Eukaryotes 
 E.coli S. cerevisiae B.taurus H.sapiens 
 
 
F1 
3 α α α α 
3 β β β β 
1 ϒ ϒ ϒ ϒ 
1 ε δ δ δ 
1 - ε ε ε 
 
 
 
 
F0 
1 δ 5 or OSCP OSCP OSCP 
1 a 6  a a or Atp6p 
1 - 8 8 or A6L A6Lor 
Atp8p 
10-15 c10-12 910 or c10 C8 C8 or 
Atp9p 
1-2 b2 4 or b b b or Atp4p 
1 - d d d 
1 - h F6 F6 
1 - f f f 
1-2 - e e e 
t.b.d* - g g g 
Species 
specific 
subunits 
1  i - - 
t.b.d* - k - - 
1 - - Coupl. 
fact.B 
- 
Inhibitor 
Protein 
0-1 - Inh1 or IF1 IF1 IF1 
Stabilizing 
factor  
for IF1 
t.b.d*  Stf1 - - 
t.b.d* - Stf2 -  
 
Associated 
proteins 
 - - AGP or 
DAPIT 
AGP or 
DAPIT 
 - - MLQ or 
6.8 PL 
MLQ or 
6.8 PL 
Table 1 Sub-unit composition and nomenclature of the ATP synthases from prokaryotes (E.coli) and 
Eukaryotes (Saccharomyces cerevisiae, Bos taurus and Homo sapiens) 
*t.b.d- to be determined 
This asymmetry supports the binding change mechanism theorized by Boyer (Boyer, 1997), 
according to which the sequential interconversion between these different conformations, 
driven by the central stalk rotation, enables the catalysis (Figure 1.5). More recent findings 
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established that this first structure represents the ADP-inhibited state of the enzyme and a 
new structure of a state in the catalytic cycle has been obtained showing that the ATP bound 
to βDP and not the ATP bound to the βTP-site is the nucleotide that is poised to form the 
transition state and then be hydrolysed (Bowler et al., 2007). Differently from β, the three α 
subunits adopt the same conformation, but are named according to their adjacent β. The 
rotation occurs in opposite during ATP synthesis and hydrolysis, resulting in different 
sequences and specific interconversion of catalytic sites (Figure 1.5).  
 
Figure 1.5 Change of the states of three β subunits during hydrolysis or synthesis of one ATP. From 
(Yoshida et al., 2001) 
First direct visualization of ATP-driven rotation of Bacillus F1 immobilized on the 
glass surface via the N-termini of its β-subunits was obtained more than 10 years ago (Noji et 
al., 1997). These experiments showed that a fluorescent actin filament attached on the γ-
subunit rotates uni-directionally, counterclockwise when viewed from membrane side, upon 
addition of ATP (Figure 1.6). A further technical sophistication used a sub-millisecond 
resolution camera to detect the rotation of gold beads attached to the γ subunit of the α3β3γ 
sub-complex along with fluorescence changes of an ATP hydrolysable analog. This 
technique allowed to display in real time the binding and release of nucleotides at the three 
catalytic sites simultaneously with the γ rotation (Adachi et al., 2007).The rotation probe 
reports a pause, which corresponds to the period during which ATP binds to the empty 
catalytic site, and a 120° step rotation, constituted by two sub-steppings, whose duration is 
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still debated, during which ATP hydrolysis and release occur. Single molecule technology 
studies have been applied also to the whole F0F1 complexes (Zarrabi et al., 2005) from 
Propionigenium modestum and Escherichia coli. Rotation was probed with probes attached 
to the c-ring in the immobilized F0F1 and, as expected, occurred in the opposite direction 
when c-ring rotation was driven by ATP or by proton-flow (Ueno et al., 2005). 
 
Figure 1.6 Image depicts the fixation of (αβ)3 cylinder on a glass plate with three different types of probes 
attached to γ subunit. In the first case a fluorescent labeled actin filament was attached while in the second 
case a single fluorescent dye molecule was attached. In the third case a gold bead or polystyrene was 
attached(Yoshida et al., 2001). 
Stepwise γ rotation has also been proven by FRET (single-molecule fluorescence resonance 
energy transfer). In their pioneering study, Diez et al. incorporated double-labeled F0F1 ATP 
synthase from E. coli into liposomes and demonstrated that γ subunit rotates during proton 
transport-powered ATP synthesis, showing three distinct distances to b subunits in repeating 
sequences (Diez et al., 2004). 
1.2.2 ATP synthase interactors 
The ATP synthase activity is optimized by reversible association of regulatory 
peptides and by biochemical events, such as protein kinase-mediated phoshorylation. Some 
of these interactors induce the enzyme inhibition, such as the inhibitor protein IF1 (Bason et 
al., 2011), which inhibits the ATPase activity by binding to F1 moiety at low pH and 
membrane potential, the Protein Kinase C which interacts with the d subunit of the F0F1 
lateral stalk (Nguyen et al., 2010) and Cyclophilin D which binds to the peripheral stalk 
(Giorgio et al., 2009). Other interactors conversely improve the enzyme performance, such as 
the proteins S100A1 which interacts in a Ca
2+
-dependent manner in cardiomyocytes 
(Boerries et al., 2007), Bcl-XL which increases the aerobic ATP production in healthy 
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neurons by decreasing the membrane leak conductance (Alavian et al., 2011) and Factor B, a 
redox-sensitive coupling factor which possibly bind to the F0 sector (Belogrudov and Hatefi, 
2002;  Lee et al., 2008). Considering that IF1 plays a fundamental role in modulating also the 
ectopic ATP synthase, which is the topic of the present thesis, a more detailed description is 
presented. 
1.2.2.1 IF1 
IF1 binds the F1 sector in a 1:1 stoichiometry in the presence of Mg
2+
 and ATP 
(Gledhill et al., 2007) and completely inhibits, through a non-competitive mechanism, the 
ATP-hydrolyzing activity of ATP synthase without affecting the synthesis of ATP during 
oxidative phosphorylation (Faccenda and Campanella, 2012;  Green and Grover, 2000).  IF1 
is reported to be largely active only at low pH (Harris et al., 1979;  Panchenko and 
Vinogradov, 1985), hence in conditions where ATP hydrolysis, rather than ATP synthesis, 
would occur. Therefore, IF1 is considered essential for maintaining the cellular level of ATP, 
by preventing its hydrolysis, when the H
+
 electrochemical gradient ΔµH across the 
mitochondrial inner membrane is lost (e.g. during hypoxic/ischaemic conditions) and the 
enzyme reverses its activity to transiently restore the membrane potential (Di Pancrazio et al., 
2004;  Lippe et al., 1988). IF1 therefore preserves ATP at the expense of ΔµH (Campanella et 
al., 2009). 
IF1 was discovered in 1963 by Pullman and Monroy in mitochondria from bovine 
heart. To date, IF1 homologues have been isolated from mitochondria of other mammals (Di 
Pancrazio et al., 2004), yeast (Venard et al., 2003) and plants (Norling et al., 2005). In bovine 
heart IF1 is a small, basic, heat-stable protein of 84 amino acids encoded by nuclear DNA, 
whose molecular structure has been characterized both in solution (Cabezon et al., 2001) and 
bound to F1 (Bason et al., 2011;  Gledhill et al., 2007). The N-terminal region, which is 
largely -helical, contains the inhibitory sector, while the C-terminal, which is also -helical, 
holds together two monomers in a homo-dimer by an antiparallel coiled coil. In solution two 
homo-dimers can associate to form tetramers at neutral pH (Cabezon et al., 2001). At low pH 
each inhibitory sector of the IF1 homo-dimer binds to one of the three catalytic sites of two F1 
holding them together in solution (Gledhill et al., 2007). Such finding prompted to propose 
that IF1 can promote dimerization of F0F1 complexes in membrane (Garcia et al., 2006), but 
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genetic deletion of IF1 in yeast (Dienhart et al., 2002) and its physical release in bovine 
(Tomasetig et al., 2002) did not alter F0F1 dimerization, keeping still open this question (see 
also section 1.2.4). The recent crystal structure of one F1 complex  from beef inhibited with 
residues 1-60 of IF1 (Bason et al., 2011) (Figure 1.7) established that IF1 is bound at a 
catalytic interface between the DP and DP subunits and two inhibitory ADP-Mg complexes 
are trapped in the catalytic sites of both DP and TP subunits arresting the catalytic cycle. 
Interestingly, a comparison of the structures of bovine and yeast F1 inhibited by their cognate 
inhibitor proteins has shown differences in binding mode (Bason et al., 2011), in spite of the 
high homology of the N-term inhibitory region and this may be consistent with the 
differences in the mechanism of inhibition recently proposed for the yeast IF1 (Corvest et al., 
2007).   
 
Figure 1.7 The structure of bovine F1-ATPase inhibited with residues1-60 of the bovine inhibitor protein 
IF1 (Bason et al., 2011). The α, β, γ, δ and ε are shown in red, yellow, dark blue, magenta and green 
respectively while the inhibitor protein is marked in light blue. 
Despite the detailed knowledge on the biochemistry of the interaction of IF1 with F1, 
its role in cell physiology and pathology has only recently started to be discovered (Faccenda 
and Campanella, 2012).  Consistent with the well-defined action of IF1 in delaying cell death 
during heart ischemia (Rouslin et al., 1990), variations in IF1 expression have been shown to 
influence cellular resistance to hypoxic injury in different cell types, such as neurons and 
astrocytes (Campanella et al., 2008). Although IF1 over-expression has been observed long 
ago in many human carcinomas, the metabolic effects of its up-regulation are still highly 
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debated. Originally a greater protection of cancer cells against energy dissipation has been 
theorized as consequence of a higher binding efficiency of IF1 to F0F1 working in reversal 
(Chernyak et al., 1994). More recent work found that in tumor cells IF1 overexpression 
inhibits the oxidative phosphorylation causing membrane hyperpolarization and favoring the 
aerobic glycolysis by ROS-mediated activation of NFkB which results in cell proliferation 
(Formentini et al., 2012;  Sánchez-Cenizo et al., 2010). Conversely, it has been proposed that 
in the hypoxic conditions of cancer IF1-mediated membrane depolarization could protect 
tumor cells from excess ROS production and inhibit the activation of the intrinsic apoptotic 
pathways (Faccenda and Campanella, 2012), thus indicating the need for further 
investigation to shed light on this important topic. Finally, the involvement of IF1 in 
regulation of haemoglobin synthesis has been demonstrated, based on the observation that 
the loss of Atpif1gene impairs haem synthesis in zebrafish, mouse and human 
haematopoietic models as a consequence of diminished ferrochelatase activity and elevated 
mitochondrial pH (Shah et al., 2012). 
1.2.3 The ATP synthase assembly process in mitochondria 
The mitochondrial F0F1 complex is composed of both nuclear and mitochondrial gene 
products. In yeast the three F0 core proteins a, A6L and c, named Su6, Su8 and Su9 
respectively,  are encoded by mtDNA, while in mammals only subunits a and A6L are 
encoded by mitochondrial genome. This arrangement highlights the complexity of enzyme 
assembly, which requires accessory factors, whose definition is still under investigation 
(Wittig and Schägger, 2008). Altogether 9 factors have been identified in yeast, but, until 
now, the role of only five of them has been defined. Three factors mediate the F1 formation 
(Atp11p, Atp12p and possibly Fmc1p) (Ackerman, 2002;  Lefebvre-Legendre et al., 2001) 
and two the F0 assembly (Atp10p and Atp22p) (Helfenbein et al., 2003;  Rak et al., 2011). In 
mammalian cells only two factors are known, which are orthologus to yeast F1 assembly 
factors. 
The assembly process is best characterized in yeast, where recent in organello pulse-
labeling and pulse-chase experiments have enabled to identify three different assembly 
intermediates and to demonstrate that the whole enzyme is formed by two separate pathways 
that converge to form the ATP synthase from their respective end-products. One pathway 
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leads to the formation of F1, which was already known to assemble as an independent unit 
(Tzagoloff, 1969), and of the Su9- ring. These two sub-complexes subsequently combine to 
constitute the F1/Su9-ring end-product. The other pathway leads to the formation of the 
Su6/Su8/stator sub-complex, which, in addition to Su6 and Su8, contains the chaperone 
Atp10p and additional still undefined proteins of the lateral stalk (Rak et al., 2011) (Figure 
1.8). Interestingly, as the Figure shown, in their experiments these authors did not detect 
OSCP in the Atp6p/Atp8p complex, this could mean that OSCP assembly occurs later, in 
accordance with previous results (Devenish et al., 2000).  
It has been proposed that this bifurcated process may recapitulate some of the 
evolutionary events that gave rise to this enzyme. The F1/Atp9p ring intermediate could be 
the product of an evolutionary event, which enabled a passive channel to be converted to an 
active ion transporter. The function of the ancestral protein from which the 
Atp6p/Atp8p/stator complex evolved is more difficult to envision. Its function may have 
been adapted to further modify the ATP-dependent ion pump into the present energy 
transforming machine (Rak et al., 2011). 
 
Figure 1.8 Assembly of ATP synthase in Saccharomyces cerevisiae. The diagram shows the two separate 
pathways for assembling the immediate precursors of the ATP synthase. In this scheme, the ATP synthase is 
composed of at least three different modules, F1, the Atp9p ring and the Atp6p/Atp8p/stator subcomplex. At 
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present we cannot exclude the possibility that the stator is also a separate module that interacts with the 
Atp6p/Atp8p subcomplex as a preformed unit (Rak et al., 2011). 
1.2.4 Self-association of ATP synthase in mitochondria 
ATP synthase is commonly isolated as a functional monomer, but now it is widely 
accepted that this is not the physiological state in the membrane. Several studies of electron 
microscopy of native mitochondrial membranes from Paramecium multimicronucleatum 
(Allen et al., 1989), yeast (Thomas et al., 2008), algae (Dudkina et al., 2005), plants (Eubel et 
al., 2003) and mammals (Strauss et al., 2008) demonstrate that ATP synthase is organized in 
dimers associated to form long rows of oligomers. The physiological role of these 
supramolecular structures is linked to the mitochondrial morphology (Paumard et al., 2002): 
genetic deletion of the F0 subunits e and g in Saccharomyces cerevisiae leads the loss of the 
dimeric and oligomeric structures of the complex and of the cristae organization of the inner 
mitochondrial membrane. This role has been further demonstrated by a recent electron 
cryotomagraphy study showing that in different types of mitochondria (bovine heart, potato 
and three fungi) ATP synthase dimers and oligomers are present on tightly curved cristae 
edges (Davies et al., 2011) (Figure 1.9). 
 
 
 
 
 
 
 
Figure 1.9 ATP synthase oligomers in the mitochondria cristae. The ATP synthase forms dimers rows 
(yellow) at the cristae tips, whereas the proton pumps of the electron transfer chain (green) reside 
predominantly in the adjacent membrane regions (Davies et al., 2011). 
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Mutational analyses and cross-linking experiments combined with native 
electrophoresis in yeast established that two monomers interact to form dimers through e/g, 
4/4 and 6/6 interactions and a raw topological model has been recently presented (Velours J. 
et al., 2011).  In addition to these F0 subunits, subunit h in yeast (Fronzes et al., 2006), Factor 
B in bovine (Lee et al., 2008) and IF1 in bovine and rat (Garcia et al., 2006) have been 
proposed to promote dimerization of F0F1. In consonance with IF1 involvement, it has been 
reported that overexpression or down-regulation of IF1 promotes or diminishes cristae 
formation in the mitochondria of cultured mammalian cells, respectively (Campanella et al., 
2008). These authors also observed a higher ATP synthesis flux induced by IF1 
overexpression, suggesting that F0F1 self-association may favor effective ATP synthesis. This 
is consistent with the view that ATP synthase oligomerization may cause a higher local 
proton concentration due to local membrane curvature (Strauss et al., 2008). However, 
controversial results have been reported (see also section 1.2.2.1) 
Although it is well accepted that dimers associate to form oligomers in membrane, the 
structural organization of these latter is still debated. Based on the numerous mutational and 
cross-linking experiments a topological model has been recently proposed for yeast 
oligomers, where subunit e and g of F0 and subunit h of the peripheral stalk are involved in 
oligomer formation or stabilization (Habersetzer J et al., 2012). Consistent with these data,  
(Bisetto et al., 2008) demonstrated that the F0 subunit e is critical for oligomers formation 
also in bovine. In fact, selective degradation of subunit e, without disrupting membrane 
integrity or ATPase capacity, altered the oligomeric distribution of ATP synthase, by 
eliminating oligomers and reducing dimers in favor of monomers (Bisetto et al., 2008). 
A 3D reconstitution model of oligomers has been derived from transmission EM 
images of yeast dimers, where two adjacent dimers are packed together through their 
peripheral stalks (Couoh-Cardel et al., 2010) (Figure 1.10).  Such a diagonal model is 
consistent with the offset observed by Allen (Allen et al., 1989) in the first direct 
demonstration of the ATP synthase oligomer in tubular mitochondrial cristae and the images 
of atomic force microscopy (Buzhynskyy et al., 2007). In this model, the curvature of the 
membrane can then be induced either by the intrinsic angle of the dimer and/or by the 
curvature induced by interdimeric distances at interfaces forming the oligomer. However, a 
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computer simulation has very recently proposed that the assembly of the dimer rows is not 
driven by direct protein contacts, rather by the reduction of the plastic deformations induced 
by isolated dimers in the lipid bilayer (Davies et al., 2011). Moreover, the last structure of 
intact bovine mitochondrial ATP synthase at 18 Å resolution shows that e- and g-subunits 
extend from the a-subunit density distal to the c8-ring, suggesting that monomers are 
sufficient to produce curvature in lipid bilayer (Baker et al., 2012). 
 
Figure 1.10 Model of the ATP synthase oligomer. The central 2-fold axis of each monomer was moved along 
a diagonal direction to get a close contact of inter-dimer peripheral stalks. Such an inter-dimer contact of the 
peripheral stalks would explain the cross-linking data observed for the in vivo oligomer  (Couoh-Cardel et al., 
2010). 
1.2.5 Disorders of mitochondrial F0F1 ATP synthase 
In spite of the fact that the assembly process of the mitochondrial ATP synthase is 
still poorly characterized in humans, its defects have been recognized as a cause of  human 
diseases (Houstek et al., 2006;  Kucharczyk et al., 2009). Alteration of ATP synthase 
biogenesis leading to mitochondrial ATP synthase deficiency may cause two types of 
defects: qualitative when the enzyme is structurally modified and does not function properly, 
and quantitative when it is present in insufficient amounts. Examples of qualitative defects 
are those caused by missense mutations in the mitochondrially-encoded subunit a gene. Eight 
point mutations and a two-nucleotide micro-deletion in the ATP6 gene have been identified, 
of which the most common and best studied is the T8993G mutation that leads to 
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replacement of a highly conserved leucine by arginine (Kucharczyk et al., 2009). These 
mutations prevent ATP synthesis but not ATP hydrolysis because mutated F0 can translocate 
protons from the cytosol to the mitochondrial matrix, thus sustaining membrane potential 
(Sgarbi et al., 2006). The impaired ATP synthesis mainly affects brain tissue and at high 
mutation load, up to approximately 95%, the heteroplasmic ATP6 gene mutations manifest as 
neuropathy, ataxia, retinitis pigmentosa (NARP) or as fatal encephalopathy known as Leigh 
syndrome (Houstek et al., 2006). Other mutations had been found in mitochondrially 
encoded subunit A6L and nuclear encoded subunit ε, assembly factor ATP12 and an 
ancillary factor TMEM70. Most of these mutations are harmful and give rise to severe 
mitochondrial diseases such as the neonatal mitochondrial encephalo(cardio)myopathy and 
dysmorphic features in patients with an ATP12 or TMEM70 gene mutation (Harris and Das, 
1991;  Jonckheere et al., 2012). 
Examples of quantitative defects are those in which the cellular content of the enzyme 
is reduced to less than 30%. Apparently, these disorders are caused by different nuclear 
genetic defects that remain to be identified, but most of them display a uniform fatal 
phenotype with onset in newborns characterized by lactic acidosis and hypertrophic 
cardiomyopathy (Houstek et al., 2006).  In both types of ATP synthase disorders, 
hyperpolarization due to decreased ATP synthesis promotes ROS production by the 
respiratory chain, an event that can contribute to the clinical phenotypes as suggested by the 
beneficial effect of antioxidants observed in NARP cells (Mattiazzi et al., 2004). This finding 
is quite important, considering that, in spite of the considerable progress in understanding of 
the molecular mechanisms of ATP synthase disorders, the available therapeutic approaches 
are still extremely limited (Kucharczyk et al., 2009).  
Microarray analyses have been performed in an attempt to gain a more global view of 
the cellular consequences of ATP synthase deficiency. In fibroblast cell lines from 13 
genetically heterogeneous patients, 1632 human genes involved in mitochondrial biology, 
cell cycle regulation, signal transduction and apoptosis have been analysed. Surprisingly, 
only minor changes in expression of ATP synthase related genes were shown. Moreover, the 
cellular gene expression phenotypes were different depending on the site (mtDNA vs nuclear 
DNA) and the severity (ATP synthase content) of the underlying defect, indicating the need 
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for further investigation of these pathways in other ATP synthase disorders (ížková et al., 
2008).  
Other intriguing examples of ATP synthase-related diseases are Batten disease in man 
or ceroid lipofuscinosis in sheep.  Both are storage diseases with abnormal accumulation of 
subunit c in lysosomes occurring in the brain and liver, respectively.  Mass spectrometry and 
protein sequencing have shown that the stored protein is structurally identical to the normal 
mitochondrial subunit c (Chen et al., 2004).  
Up- and down-regulation of ATP synthase biogenesis has been observed under 
different pathophysiological conditions (Houstek et al., 2006). By using polyspecific 
antibodies directed against the whole human mitochondrial subproteome up-regulation of 
ATP synthase has been observed in muscle biopsies from patients affected by MELAS 
(mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) which are 
characterized by a drastic reduction of OXPHOS complex 1 (Loro et al., 2009). Recent 
examples of ATP synthase down-regulation have been obtained by the mitochondrial 
proteome analyses in heart from type 2 diabetic patients (Heather and Clarke, 2010) and in 
pancreatic β-cells exposed to high glucose (Ahmed et al., 2010).  
1.3 Cell surface or ectopic F0F1 ATP synthase 
Although previously the ATP synthase was thought to be confined to the inner 
mitochondrial membrane, recent immunofluorescence, proteomic and functional studies have 
demonstrated the presence of subunits of both the F1 and F0 sector on the cell surface of wide 
variety of normal and tumor cells. The first instance of these reports was observed in 1994 
when Das et al demonstrated the presence of α and β subunits on the surface of the tumor cell 
line A549 (Das et al., 1994), following which Moser et al identified the β subunit as a new 
receptor for angiostatin on the cell surface of human endothelial cells (Moser et al., 1999). 
After these pioneering works a large number of reports has demonstrated the presence of 
ATP synthase components on the cell surface of various cell types (Vantourout et al., 2010), 
using immunofluorescence, cell surface biotinylation, mass spectrometry and other 
techniques, as outlined in Table 2 (see also section 1.3.2).  
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Due to its cell surface expression the enzyme has been designed cell surface or 
ectopic F1-ATPase/ATP synthase, although the exact structure of this ectopically-expressed 
complex has not been definitely determined. The interesting thing to note about this enzyme 
is its orientation on the cell surface. The enzyme has an opposite orientation in plasma 
membrane of eukaryotic cells with its F1 sector protruding into extracellular side as 
compared to that of bacterial ATP synthase, whose F1 sector is located in the cytoplasm. 
Such localization implies that ATP synthesis or hydrolysis occurs in the extracellular space 
of the cells potentially affecting the extracellular ADP/ ATP levels and is consistent with its 
well defined role in mediating downstream cell signaling via purinergic receptors (Figure 
1.11).  
 
Figure 1.11 Model depicting the orientation of ATP synthase in plasma membranes of eukaryotic cells 
and bacteria. In eukaryotic cells the orientation is just opposite to that of bacterial enzyme with F1 sector 
located in extracellular space and F0 embedded in plasma membrane. In some cells the ATP synthesized leads 
to influx of Ca
2+
 through P2X receptors and in others the ADP generated by ATP hydrolysis triggers signaling 
pathways through activation of G-protein coupled P2Y receptors. 
As already mentioned, the first demonstration of its implication in cell signaling has been 
obtained in endothelial cells, where the ectopic enzyme has been characterized as the 
receptor of angiostatin, an inhibitor of angiogenesis originating from the proteolysis of 
Bacterial Eukaryotes 
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plasminogen (Moser et al., 1999).  The anti-angiogenic activity of angiostatin has been later 
attributed to its ability to inhibit ATP synthesis sustained by the ectopic enzyme, thus 
eliminating a significant source of energy and reducing proliferation. It was also proposed 
that this inhibition prevents the extrusion of protons by the ectopic enzyme, thus lowering 
intracellular pH and hampering cell survival (Chi and Pizzo, 2006). 
 
Cells/ tissues 
Subunits 
identified 
Methods of 
detection 
References 
K562, erythroleukemic A549, lung 
adenocarcinoma Raji, Burkitt’s 
lymphoma 
β subunit B, FC, S (Das et al., 1994) 
HUVEC (human umbilical 
vein endothelial cells) 
α and β subunits 
and IF1 
B, FC, CM 
(Moser et al., 
2001;  
Radojkovic et 
al., 2009) 
HepG2 (hepatocellular carcinoma) 
and IHH (immortalized human 
hepatocyte) 
α and β subunits 
SPR, FC, CM, 
ATP-A 
(Martinez et al., 
2003) 
3T3-L1 (murine adipocytes) α and β subunits B, CM 
(Kim et al., 
2004) 
Jurkat cells β subunit RP+MS 
(von Haller et 
al., 2001) 
Rat hepatocytes 
α, β, γ, δ, b, d, 
e, F6, OSCP 
subunits 
CM, RP+MS 
(Bae et al., 2004;  
Mangiullo et al., 
2008) 
HaCat, Human Skin β subunit RP+MS, CM (Burrell et al., 
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2005) 
Osteosarcoma α, β, d subunits CM 
(Yonally and 
Capaldi, 2006) 
Neurons, neuroblastoma α subunit B, CM 
(Xing et al., 
2010) 
Rat tonsils β subunit PM 
(Park et al., 
2004) 
Influenza virus β subunit MS, CM 
(Gorai et al., 
2012) 
HIV-1 and Antigen presenting cells α and β subunits B, CM, MS 
(Yavlovich et al., 
2012) 
Colon endothelial cells (CACO-2) β subunit SPR, CM 
(Kowalski-
Chauvel et al., 
2012) 
Neurofibrillary tangles of 
Alzheimer’s disease 
α subunit EM 
(Vacirca et al., 
2011) 
Breast cancer cell line α subunit MS (Pan et al., 2011) 
Table 2 Ectopic F0F1 ATP synthase detection in various cell types (Vantourout et al., 2010). The 
experimental approaches used in the studies were B- cell surface biotinylation, FC- flow cytometry, S- 
sequencing, CM- confocal microscopy, SPR- surface plasmon resonance, RP+MS- raft purification and mass 
spectrometry, PM- plasma membrane extraction 
In hepatocytes, Martinez et al demonstrated that the ectopic β chain is a high affinity 
ApoA1 receptor which stimulates ATP hydrolysis by ectopic F1-ATPase (Martinez et al., 
2003) and in turn activates the P2Y13 purinergic receptor mediating HDL endocytosis 
(Pandey et al., 2009). In accordance, it has been found that induction in hepatic HDL 
secretion is associated with reduced expression of the ectopic complex (Pandey et al., 2009). 
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As shown for hepatocytes, ApoA1 activates the hydrolytic activity of the ectopic F1-ATPase 
also on endothelial cells, stimulating cell proliferation and inhibiting apoptosis (Radojkovic 
et al., 2009). This indicates that endothelial cell survival is regulated by ADP-sensitive 
receptors and intracellular signaling pathways, which are still not characterized.  
Besides these two important roles, the ectopic enzyme has been implicated in tumor 
cell recognition by V9/Vδ2 T lymphocytes, which are known to bind small alkyl 
diphosphate molecules termed phosphoantigens on target cells. The first work was based on 
the observation that these lymphocytes recognize the ectopic F1-ATPase on the surface of 
tumor cells through their T cell receptors (TCR) and that ApoA1 enhances the cell response 
(Scotet et al., 2005). Later work established that the ectopic ATP synthase molecules bind 
and convert to nucleotidic derivates the phosphoantigens produced by the tumor cells in 
order to present them to the V9/Vδ2 T lymphocytes (Mookerjee-Basu et al., 2010).  
ATP synthase subunits are not the only mitochondrial proteins found on cell surface. 
Different research groups demonstrated the presence of subunits of the four respiratory chain 
complexes in different cells using confocal microscopy (Yonally and Capaldi, 2006) or mass 
spectrometry analyses of lipid raft preparations (Bae et al., 2004) and evidence of their 
enzymatic reactions have been also obtained (Ravera et al., 2009).  
Consistent with its role in cell signaling, the ectopic ATP synthase seems to be 
mainly localized in lipid rafts (Kim et al., 2004), which are plasma membrane microdomains 
rich in cholesterol and sphingolipids harboring various signaling molecules. Lipid rafts are 
involved in other cellular functions including entry to pathogens, cholesterol homeostasis and 
angiogenesis (Zheng et al., 2009). Due to the fact that these domains are resistant to 
extraction by cold Triton X-100 treatment they are designed detergent-resistant membranes 
and can be isolated by a variety of different methods (Ilangumaran and Hoessli, 1998;  Zheng 
et al., 2009). Flotillin and caveolin, which are proteins involved in membrane trafficking and 
endocytosis, are widely used as lipid raft markers during the purification protocols (Glebov et 
al., 2005).  
Protein identification of lipid rafts, which is essential to study their function, still 
represents a challenge of proteomic research. Beside plasma membrane proteins, lipid raft 
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proteome analyses from various mammalian cells and tissues has revealed that these contain 
many proteins from unexpected locations such as mitochondrial proteins and endoplasmic 
reticulum proteins which had been initially considered cross-contamination, due to the 
contiguity of the different membranes within the cell. The parallel demonstration of their 
locations on cell surface obtained by immunofluorescence and functional studies led to 
consider these proteins as true residents on the plasma membranes (Panfoli et al., 2011). In 
particular, 12 mitochondrial proteins, including  and  subunits of ATP synthase, were 
identified as ubiquitous raft proteins, being been found in lipid rafts obtained from different 
organ tissues such as liver, lung, brain and kidney (Kim et al., 2004). In accordance, in 
another study on lipid rafts isolated from rat liver, along with α and β subunits,  the presence 
of the F1  and δ subunits and the F0 b, d, e, F6 and OSCP subunits was demonstrated by LC-
MS/MS analyses (Bae et al., 2004). These findings are consistent with the patchy pattern of 
the ectopic enzyme revealed by confocal microscopy, which is reminiscent of several 
proteins residing in lipid rafts. However, evidence has been obtained that the presence of the 
ectopic ATP synthase in lipid rafts is not exclusive (Vantourout et al., 2010). 
1.3.1 Imaging and detection of ectopic F0F1 ATP synthase 
As already mentioned, besides mass spectrometry, different techniques have been 
used to confirm the presence of the ectopic ATP synthase subunits on the surface of various 
cell types, such as cell surface biotinylation, surface plasmon resonance and 
immunoprecipitation (Vantourout et al., 2010). Among all confocal microscopy was most 
widely used. Moser et al. in 2001 for the first time showed the co-localisation of α and β 
subunits on the surface of HUVEC by immunostaining the non-permeabilized cells with the 
respective antibodies (Moser et al., 2001). Later studies confirmed the ectopic localization of 
these subunits in numerous cell types, as outlined in Table 2. Further work demonstrated the 
presence of other subunits, i.e. b,  and OSCP on rat hepatocytes (Mangiullo et al., 2008) and 
of the inhibitor IF1 in endothelial (Cortes-Hernandez et al., 2005) and HepG2 cells (Contessi 
et al., 2007). Confocal microscopy was also used to examine in HepG2 cells the effects of 
niacin, which markedly inhibits the β subunit expression, leading to a reduced hepatic 
removal of HDL (Zhang et al., 2008). Along with ATP synthase, subunits of three (Yonally 
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and Capaldi, 2006) or four (Kim et al., 2006) respiratory chain complexes were found present 
at the surface of osteosarcoma and HepG2 cell lines.  
1.3.2 How ectopic F0F1 reaches to cell surface? 
The mechanism used by ATP synthase to reach the plasma membrane is still 
unknown ( Soltys and Gupta, 1999; Vantourout et al., 2010). The hypothesis that the single 
ATP synthase subunits are routed to plasma membrane instead of the mitochondria seems 
unlikely, because different mRNA isoforms of ATP synthase subunits have not been found in 
mammals apart for the bovine subunit c (Vives-Bauza et al., 2011). An alternative putative 
transport mechanism is transient fusion of mitochondria with target membranes, which would 
explain re-localization to other destinations, but such a fusion event would involve only the 
outer membrane and ATP synthase is located in the inner one. Another potential mechanism 
for re-localization of proteins to extra-mitochondrial sites might occur via vescicular 
transport, based on the well-recognized intimate associations between mitochondria and the 
ER (Raturi and Simmen, 2013), whose interaction is mediated by Mitofusin 2, allowing the 
exchange of Ca
2+
 between those organelles (Rusinol et al., 1994). In recent reports, 
mitochondria-derived vesicles containing a new outer membrane ligase named MAPL or 
Tom20 ((Braschi et al., 2009) have been described, but their fate is still under investigation.   
Till now no solid proof has been presented to ensure whether enzyme is translocated 
or it’s just the fusion of mitochondrial membrane with plasma membrane. In an interesting 
report (Ma et al., 2010), evidence has been obtained that the ectopic expression of ATP 
synthase is a consequence of translocation from mitochondria. In fact, two fusion proteins of 
ATP synthase  subunit and GFP with and without the mitochondrial transit peptide were 
introduced into HepG2, but only the protein with the mitochondrial transit peptide was able 
to reach the plasma membrane. Consistent with this finding, some conditions have been 
described which affect the enzyme expression on cell surface. Cholesterol loading causes 
translocation of β subunit from mitochondria to the cell surface of HeLa cells without any 
increase in the expression of protein (Wang et al., 2006), while niacin, the clinically used 
drug to elevate plasma-HDL level, acts by inhibiting the surface expression of β subunit 
(Pandey et al., 2009). In cholestatic rats, which show a dramatic alteration in plasma lipid 
profile, an increase in IF1 binding to ectopic F1 was found in liver, causing a mark inhibition 
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of its ATP hydrolysis (Giorgio et al., 2010), which is consistent with the observations that 
perfusion with exogenous IF1 was able to reduce HDL uptake by rat liver (Martinez et al., 
2003). Moreover, in HUVEC cells, the ectopic IF1 expression underwent variations upon 
stimulation with TNFα (Cortes-Hernandez et al., 2005) and in neurons deficiency in 
palmitoyl protein thioesterase 1 (Ppt1), which is responsible for the infantile ceroid 
lipofuscinosis syndrome, was linked with an increase in ectopic F1 expression (Lyly et al., 
2008).  
In conclusion, the simpler explanation seems that after getting assembled into 
mitochondria the whole ATP synthase is routed to cell surface by vesicular transport rather 
than each subunit being translocated and getting assembled in plasma membrane, also 
because the expression of assembly factors in extramitochondrial locations has not been 
reported (Vantourout et al., 2010). An intriguing aspect is related to the mitochondrial 
encoded subunits a and A6L, because it seems very unlikely they are targeted to plasma 
membrane. Interestingly, these subunits have not yet identified in the ectopic enzyme, while 
their detection could be a strong proof in favor of the transport of the whole complex to cell 
surface after being assembled into mitochondria.  
1.3.3 Is ectopic F0F1 ATP synthase able to synthesize ATP? 
The question whether the ectopic F0F1 ATP synthase can synthesize ATP from ADP 
and Pi extruding protons from cytoplasm is very intriguing. The first demonstration of 
extracellular ATP synthesis by ectopic ATP synthase was done on endothelial cells, where its 
inhibition by angiostatin caused inhibition of angiogenesis in proliferating tumors (Burwick 
et al., 2005;  Moser et al., 2001). In contrast, IF1 did not inhibit the extracellular ATP 
synthesis, similarly to what happens in mitochondria, and the endothelial cell differentiation 
was unaffected. The group reported that angiostatin inhibited ectopic ATP synthase over a 
wide pH range (6.5-7.5), although the effect was enhanced at extracellular pH similar to that 
of many tumors (pH 6.5). Although potentially promising, angiostatin is not used in clinic, 
because it is rapidly cleared from the blood circulation after intravenous administration, and 
new angiostatin mimetics are actually searched (Wahl et al., 2005). 
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After this finding lots of independent studies demonstrated the extracellular ATP 
synthesis in many different cell types, such as adipocytes (Kim et al., 2004), keratinocytes, 
HUVEC (Arakaki et al., 2003), neuronal cells (Xing et al., 2010), C6-glioma cells (Ravera et 
al., 2010), retinal cells (Panfoli et al., 2009), hepatocytes (Mangiullo et al., 2008) etc, where 
the resulting ATP triggers cation influx into the cells through ATP-gated ion channels (P2X 
purinoreceptors) or binds to G-protein coupled receptors (P2Y purinoreceptors) activating a 
downstream signaling pathways (Mowery and Pizzo, 2010). However, it is still not certain 
whether a proton motive force exists on the surface of membrane sufficient to drive the 
synthesis of ATP and many groups reported that ATP synthesized extracellularly was due to 
adenyl kinase which uses two molecules of ADP to synthesize ATP (Vantourout et al., 
2010).  
1.3.4 Ectopic F0F1 ATP synthase/ ATPase: implications in various diseases 
After the discovery of β subunit of ATP synthase on the cell surface of tumor cells by Das et 
al in 1999, there emerged numerous reports citing an altered presence of various subunits of 
this enzyme on cell surface in different diseases here outlined. 
1.3.4.1 Ectopic F0F1 ATP synthase, HIV and influenza 
AIDS progress by destroying the CD4+ cells of the immune system. Antigen 
presenting cells including dendritic and beta cells play a major role in disease progression. 
These cells act as vehicles that transfer to CD4+ cells the viral particles which in turn activate 
them to produce high level of HIV particles. This transfer from CD4+ cells occurs through an 
intercellular junction termed as virological synapse. Yavlovich et al demonstrated that the 
ectopic ATP synthase facilitates the transfer of HIV1 particles from antigen presenting cells 
to CD4+ target cells. They found that an antibody against β subunit and known inhibitors of 
ATP synthase completely block the transfer of viral particles to target cells and demonstrated 
the co-localisation of β subunit at the junction of antigen presenting cells. Their findings 
show a novel mechanism by which the proliferation of HIV1 can be inhibited by blocking the 
β subunit of ectopic ATP synthase (Yavlovich et al., 2012). 
The ectopic ATP synthase seems also to be involved in influenza progression, being 
been found its β subunit to interact with the viral protein NS2 at the surface of target cells 
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(Gorai et al., 2012). The group demonstrated that the ATPase activity of the ectopic enzyme 
was important for the efficient influenza-virion formation and budding thus giving another 
target for drug discovery.  
1.3.4.2 Ectopic F0F1 ATP synthase and Alzheimer’s disease 
Amyloid β peptide deposits and neurofibrillary tangles in cerebrospinal fluid (CSF) 
are described as the hall marks of Alzheimers disease. In 2003 Sergeant et al demonstrated 
the implication of α chain of ATP synthase in neurofibrillary disease based on the cytosolic 
accumulation of this protein in CSF (Sergeant et al., 2003). A subsequent report 
demonstrated that amyloid precursor protein and amyloid β peptide bind to α subunit of the 
ectopic ATP synthase modulating its activity in cultured hippocampal neurons and 
astrocytes. These authors found that amyloid precursor protein and amyloid β peptide 
decrease the extracellular levels of ATP by inhibiting the enzyme activity in a similar manner 
to IF1. Interestingly they found that ATP synthase binding sequence of amyloid precursor 
protein and amyloid β peptide was almost similar to that of IF1 (Schmidt et al., 2007). 
Finally, it is interesting to mention that the ectopic ATP synthase also modulates the 
plasma HDL level in central nervous system and HDL bind the amyloid β peptide,  
preventing its deposition in the brain (Vacirca et al., 2011).  
1.3.4.3 Ectopic F0F1 ATP synthase and cancer 
Although β subunit was originally found on the surface of tumor cell lines (Das et al., 
1994), later work demonstrated the presence of the ectopic ATP synthase on the plasma 
membranes of both normal and tumor cells, raising doubts on its involvement in cancer 
progression. The observation that the catalytic activity of the ectopic ATP synthase was up-
regulated in malignant cells with respect to less malignant cells, in spite of a similar 
expression  (Ma et al., 2010), shed a positive response on its roles in cancer, which was 
confirmed by very recent works.  Chang et al showed that inhibition of β subunit on the 
surface of human A549 lung carcinoma cells using citreoviridin suppresses the growth and 
proliferation of carcinoma (Chang et al., 2012). Similarly, in breast cancer cells, which are 
characterized by an over expression of the ectopic α subunit, an antibody against α subunit 
inhibits the proliferation, migration and invasion of the cancer cells but not of normal cells 
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(Pan et al., 2011). In a similar way, inhibition of the ectopic F1-ATPase by the peptide 
hormone product of the glycine gene on the surface of cancerous colonic epithelial cells 
decreases proliferation and growth of the colonic cancer cells (Kowalski-Chauvel et al., 
2012). 
In conclusion, these small pieces of evidence highlight the important role of ectopic 
ATP synthase/ F1-ATPase in the diagnosis and pathology of various existing diseases making 
it a very good target for diagnosis and therapy. 
1.3.5 Ectopic ATP synthase - a novel concept in HDL endocytosis 
1.3.5.1 Cholesterol and its metabolism 
Cholesterol is of vital importance for the human body and forms an essential 
constituent for most biological membranes. It is the precursor for steroid hormones and 
vitamin D and it is required for the formation of bile salts. However, the presence of excess 
cholesterol in cells, and in particular in macrophages, and its accumulation in arteries can 
lead to atherosclerosis, and in turn, to other cardiovascular diseases. 
Cholesterol is mainly synthesized in liver from acetyl-CoA and transported to the 
periphery by the Low-density Lipoproteins, which are converted in the bloodstream to 
Intermediate-density (IDL) and low-density (LDL) lipoproteins by a complex metabolism. 
Cholesterol contained in LDL is finally internalized by LDL receptor pathway and is utilized 
by the different tissues. Conversely, for its disposal, cholesterol is transported from the 
periphery to the liver by the high-density lipoproteins (HDL). Once cholesterol has reached 
the liver, its conversion into bile salts is the final destination. Only a small part of hepatic 
cholesterol is not converted to bile salts and is directly secreted into bile. The majority of this 
hepatobiliary secreted cholesterol will be reabsorbed in the small intestine and only a low 
percentage will be finally excreted via the feces. This pathway has been traditionally referred 
to as reverse cholesterol transport (RCT) or centripetal cholesterol flux. Both free cholesterol 
and its esterified form are involved in RCT (Figure 1.12). Due to their role in RCT, HDL 
represent a major drug target for the development of therapies intended to reduce the risk of 
the onset and progression of cardiovascular diseases. 
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Despite of so much importance for normal body functions and physiology, very less 
is known about the fundamental aspects of intracellular cholesterol distribution, which is 
essential for many biological functions of mammalian cells, including signal transduction and 
membrane traffic. In the biosynthetic secretory pathway, cholesterol is low in the 
endoplasmic reticulum (ER), but its level increases through the Golgi apparatus, with the 
highest level in the plasma membrane comprising of 60-80% of total cellular cholesterol. In 
the endocytic pathway, the endocytic recycling compartment (ERC), containing recycling 
membrane proteins and lipids, also contains high levels of cholesterol (Fielding and Fielding, 
1997;  Maxfield and Wustner, 2002). Intracellular trafficking plays a major role in the proper 
disposition of internalized cholesterol and in the regulation of cholesterol efflux. 
In 1996, Acton et al. reported SR-B1 (Scavenger receptor class B member 1) as a 
HDL receptor for the first time. Subsequent studies in genetically modified mice confirmed 
that deletion of SR-B1 gene causes a decrease in hepatic cholesterol uptake with a parallel 
increase of HDL plasma level, while over-expression of SR-B1 leads to an increase in 
hepatic HDL cholesterol level with a decrease in plasma HDL levels, depicting the role of 
SR-B1 in reverse cholesterol transport (Rader, 2006;  van der Velde, 2010). 
SR-B1 receptor is primarily expressed in liver and steroid-producing tissues which 
bind HDL with high affinity. The main function of SR-B1 receptor is to mediate the selective 
uptake of HDL cholesterol by a mechanism distinct from the classic LDL receptor pathway 
in which there is an endocytosis of HDL particles via coated pits and vesicles. Conversely, 
SR-B1 catalyses the transfer of the cholesteryl esters from the hydrophobic core of the HDL 
particle to the cell without the transfer of the HDL apolipoproteins. Although both esterified 
and non-esterrified cholesterol are internalized by SR-BI (Rader, 2006), cholesteryl esters are 
primarily transported.  
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Figure 1.12 Pathways of HDL cholesterol uptake by the liver (Rader, 2006). HDL-CE and HDL free 
cholesterol can be directly and selectively taken up by the liver via SR-B1. Alternatively, HDL-CE can be 
transferred to ApoB containing lipoproteins by Cholesteryl ester transfer protein (CETP) and then taken up by 
the liver via LDL receptor. In the hepatocyte, CE is hydrolyzed to free cholesterol, which is either excreted 
directly in to the bile or converted to the bile acid (BA) and excreted into the bile. 
1.3.5.2 Ectopic ATP synthase mediated HDL endocytosis 
As already mentioned, in 2003 Martinez et al. demonstrated that the expression of the 
β chain of ATP synthase on the cell surface of hepatocytes is required for HDL holo-particle 
endocytosis. These authors identified the β subunit as a high affinity receptor of ApoA1 
contained in HDL and found that ApoA-1 can stimulate the hydrolysis of ATP by plasma 
membrane F1-ATPase generating ADP and promoting the endocytic uptake of HDL 
(Martinez et al., 2003). Conversely, inhibition of F1-ATPase by antibodies or selective 
inhibitors (IF1) blocks HDL endocytosis (Figure 1.13). Later work established that ADP 
binds to the purinergic receptor P2Y13 (Jacquet et al., 2005) and that the small GTPase 
RhoA and its effector ROCK 1 are activated downstream of P2Y13 (Malaval et al., 2009). 
The same group demonstrated that this pathway is controlled by cell surface adenylate kinase 
activity, which consumes ADP generated upon activation of ectopic F1-ATPase by ApoA-1 
and therefore constitutively inhibits P2Y13 and hepatic HDL endocytosis (Fabre et al., 
2006). Furthermore, the role of HDL endocytosis mediated by F1-ATPase/P2Y13 pathway in 
RCT in vivo was confirmed by generating P2Y13-deficient mice, which exhibited a decrease 
in hepatic HDL cholesterol uptake, hepatic cholesterol content and biliary cholesterol output, 
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causing a substantial decrease in the rate of macrophage-to-feces RCT (Fabre et al., 2006). In 
addition, the F1-ATPase/P2Y13 pathway resulted to be independent of SR-B1-mediated HDL 
uptake, because a partial agonist of P2Y13 stimulated HDL uptake in normal mice and in 
mice with a targeted deletion of SR-B1 in liver, but not in P2Y12-KO mice. It was therefore 
concluded that pharmacological activation of the P2Y13 might represent a new therapeutic 
target to prevent and treat atherosclerosis (Vantourout et al., 2010). More recent findings by 
Cavelier et al. demonstrated that like in hepatocytes, the apoA-I induced ATP hydrolysis by 
ectopic F1-ATPase triggers the uptake of HDL into endothelial cells via P2Y12 receptors 
(Cavelier et al., 2012). 
 
Figure 1.13 Ectopic F1-ATPase as a receptor for HDL-ApoA1. The mechanism depends on the stimulation 
of ectopic F1-ATPase by ApoA1 leading to the generation of ADP. The ADP generated stimulates the G-protein 
coupled purinergic receptor P2Y13 which mediates the HDL endocytosis.  
1.4 Native electrophoresis of F0F1 ATP synthase 
The native polyacrylamide gel electrophoresis after mild detergent extraction is a 
powerful approach for efficient separation from tissue homogenates, tissue biopsies and cell 
cultures of the whole complex of ATP synthase, as well as of assembly intermediates and 
supra-molecular structures is (Wittig et al., 2006). Following native PAGE, proteins of 
interest can be extracted in native state and analyzed by MS or electroblotted for 
immunodetection or analyzed by in-gel catalytic activity assays. In addition, subunit 
composition of the complexes can be identified by various denaturating techniques: SDS-
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PAGE, doubled SDS-PAGEs, as it was used to detect phosphotyrosine in monomer/dimers of 
ATP synthase (Di Pancrazio et al., 2006), or IEF/SDS PAGEs (Wittig et al., 2006), as shown 
in Figure 1.14. These advantages make this approach superior for functional proteomic 
analyses.  
To summarize, native electrophoresis can be used to determine the physiological 
protein-protein interactions and supra-molecular assemblies, the native protein masses and 
the subunit composition of the native proteins using 2D SDS PAGE and Western blotting, 
and finally to extract native proteins from gels for further analyses using mass spectrometry 
(Wittig and Schägger, 2008).  
 
Figure 1.14 Applications of native electrophoresis.  
1.4.1 Blue native electrophoresis (BNE) 
Blue native electrophoresis, abbreviated as BNE, was developed to isolate native 
membrane proteins and complexes on micro-scale with a very high resolution under mild 
conditions. It separates proteins in the mass range of 10 kDa to 10 MDa. It is a one-step 
technique to isolate proteins from mitochondria, whole cell lysates and tissue homogenates 
(Wittig et al., 2006). Besides BNE a similar native electrophoresis method was developed 
that is called clear native electrophoresis (CNE) with its variant high resolution CNE (hr 
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CNE). All these methods are quite similar and have been used for MS analyses, but differ in 
few aspects, which are discussed below, with their drawbacks and applications. 
From a practical stand point BNE, CNE and hr CNE differ in the composition of 
cathode buffers as well as in the mechanisms by which proteins migrate in the gel (Table 3). 
What makes BNE different from CNE and hr CNE is the incorporation of Coomassie 
Brilliant Blue G-250 both in the cathode buffer as well as in loading dye. Coomassie is an 
anionic dye; it binds to the proteins and imparts negative charge over their surface. In this 
way proteins migrate with respect to their native masses independently of their pI. During 
migration to the anode, protein complexes are separated according to molecular mass and/or 
size and high resolution is obtained by the decreasing pore size of a polyacrylamide gradient 
gel (Reisinger and Eichacker, 2006). Negative charge also helps in preventing protein 
aggregation as negative charges repel each other and this is the reason for its very good 
resolution. Furthermore, upon binding the previously detergent-solubilized membrane, 
proteins lose their hydrophobic character and become water soluble hence no further 
detergent is required in these gels minimizing the risk of detergent-dependent protein 
denaturation (Wittig et al., 2006). Besides Coomassie, the presence of Imidazole in anode 
and cathode buffer (BNE, CNE, hr CNE) helps in maintaining pH in the range 7.0-7.5, and 
incorporation of high concentration of 6-aminohexanoic acid (a zwitterionic substance) 
improves the solubilisation of membranes (Wittig and Schägger, 2008). Separation of 
proteins as blue bands helps in gel excision and recovery of blue stained native proteins by 
electroelution (Wittig et al., 2006) for further MS analysis, as recently applied for LILBID 
MS (Hoffmann et al., 2010). In most cases BNE is combined with a second dimension, 
which is either a second BNE after equilibration with a medium-mild detergent, or SDS 
PAGE for mapping of the related subunits. 
Besides all these advantages, BNE suffers from some disadvantages such as disassociation of 
detergent labile subunits from the complex and the interference of Coomassie Blue G in 
various in-gel activity assays and fluorimetric assays. 
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1.4.2 Clear native electrophoresis (CNE) 
A basic version of clear native PAGE tried to circumvent the disadvantages of BNE. 
In fact, it used the same buffers and conditions for electrophoresis but the difference was the 
absence of Coomassie dye both in cathode buffer as well as in sample buffer (Table 3). In 
this way, the detection of fluorescent label was made easy and much higher activity staining 
has been obtained on the native gels (Wittig et al., 2007). However, due to the absence of 
Coomassie there was no negative charge shift and the movement of proteins totally depended 
on their intrinsic mass and pI. Therefore CNE suffered from a poor resolution and was 
limited to proteins having a pI<7 unlike BNE where even proteins having pI>10.5 migrate 
towards anode (Wittig and Schägger, 2008). Besides that CNE even suffered from band 
broadening and protein aggregation during electrophoresis due to absence of negative charge 
(Wittig et al., 2007). Anyway, CNE offered advantage over BNE for isolation of supra-
molecular structures, including ATP synthase dimers and oligomers, being the mildest 
technique to separate mitochondrial membrane proteins. 
 BNE CNE hr CNE 
Tricine (mM) 50 50 50 
Imidazole (mM) 7.5 7.5 7.5 
Triton X-100 (% w/v) - - 0.05 
DOC (% w/v) - - 0.05 
Coomassie Blue G (% w/v) 0.02 - - 
pH (at 4ᵒC) 7 7 7 
Protein migration Native mass 
Intrinsic charge 
and mass 
Native mass 
Resolution Very good Poor 
Comparable to 
BNE PAGE 
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Table 3 Cathode buffer used in BNE, CNE and hr CNE with mode of protein migration and resolution. 
1.4.3 High resolution clear native electrophoresis (hr CNE) 
To preserve the advantages of both the techniques Wittig et al introduced hr CNE. In 
this technique cathode buffer is supplemented with a combination of colourless anionic and 
neutral detergents such as Triton X-100, Deoxycholate, or Dodecyl-β-D-maltoside (DDM) 
(Table 3). Like Coomassie dye in cathode buffer of BNE, the mixed micelles formed impose 
a charge shift on membrane protein which helps them in anodic migration with improved 
membrane protein solubility during electrophoresis. This gives a resolution comparable with 
BNE. Also there is no interference in in-gel assays due to absence of Coomassie Blue G 
making this technique superior for functional protein analyses (Wittig et al., 2007).  
An interesting recent application of hr CNE is related to the molecular 
characterization of assembly intermediates of ATP synthase in human ρ0 cells, which lack 
the mitochondrial DNA encoding subunits a and A6L (Wittig et al., 2010). By analyzing its 
subunit composition by ESI-MS/MS after excising the native band from 1D hr CN-PAGE or 
by MALDI-MS (MS/MS) after 2D hr CN-/SDS-PAGE the authors established that an 
assembly intermediate contains all the nuclear-encoded subunits and proposed that in 
mammals, differently from yeast (Hoffmann et al., 2010), the assembly of the whole enzyme 
is a linear process, along with subunits a and A6L bind at the late stage.  
1.4.4 In-gel activity staining of the OXPHOS complexes 
 The in-gel staining of OXPHOS complexes is based on the use of suitable chemical 
substrates that change color and precipitate at the position of the enzymes as they are in the 
gel due to specific enzymatic reactions occurring at a particular pH as listed in the Table 4. 
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Name of the 
complexes 
Buffers 
pH 
optimum 
Substrates Reagents 
Complex I (NADH 
dehydrogenase) 
2 mM Tris/HCl 7.4 0.1 mg/ml NADH 
2.5 mg/ml 
NBT 
Complex II (Succinate 
dehydrogenase) 
1.5 mM 
phosphate buffer, 
0.2 mM PMS 
7.4 84 mM succinate 
50 mM 
NBT 
Complex IV 
(Cytochrome c oxidase) 
0.05 M phosphate 
buffer 
7.4 
1 mg/ml 
cytochrome c 
0.5 mg/ml 
DAB 
Complex V (F0F1 
ATPase) 
35 mM Tris, 270 
mM Glycine and 
14 mM Mg
2+
 
7.8 8 mM ATP 
0.2% 
Pb(NO3)2 
Table 4 Reaction parameters for the in-gel activity staining of respiratory chain complexes (Sabar et al., 
2005;  Zerbetto et al., 1997) 
The in-gel staining of the dehydrogenase complexes (complex I and complex II) 
relies on the precipitation of formazon as blue purple crystals derived from the reduction of 
nitro-blue tetrazolium (NBT), which is initially colorless. NBT serves as a hydrogen acceptor 
directly from NADH for complex I detection (Zerbetto et al., 1997) (Figure 1.15). On the 
other hand succinic dehydrogenases (complex II) activity is dramatically enhanced by the 
addition of an artificial electron carrier such as phenazine methosulphate (PMS), which 
reacts with NBT (Wittig et al., 2007). 
For complex IV, the precise mechanism by which the oxidation and polymerization 
of 3,3’-diaminobenzidine (DAB) takes place is still under speculation. Seligman et al stated 
that DAB is a hydrogen donor to horse heart cytochrome c permitting its reduction which in 
turn gets oxidized by complex IV (Figure 1.15).  
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Figure 1.15 In-gel activity mechanisms of OXPHOS complexes (Sabar et al., 2005). Activity of complex I 
depends on the reduction of NBT to formazan by NADH. Activity of complex II requirs an electron carrier 
PMS for the reduction of NBT to formazan. Complex IV activity is based on the oxidation of DAB by 
cytochrome c. F0F1 ATPase activity is analyzed by precipitation of lead by inorganic phosphate generated 
during ATP hydrolysis. 
In-gel ATPase activity of complex V is based on the formation of white lead 
phosphate precipitate on the position of complex V. The white precipitate is the result of the 
reaction between lead nitrate (buffer) and the phosphate ions generated by complex V ATP 
hydrolysis (Figure 1.15). The standard protocol to measure the ATPase activity in BNE can 
be sometimes challenging due to very low specific activity of the complexes. Suhai et al. 
introduced a new variant based on incubation of the gel for 10 sec in a 1% v/v ammonium 
sulfide solution after the completion of in-gel activity staining. This short incubation results 
in brownish-black band with a very high intensity (Suhai et al., 2009). 
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1.4.5 Detergent extraction of native membrane proteins 
Detergents form an integral part of native electrophoresis as they allow solubilization 
of membrane proteins. An important factor to be considered for membrane solubilization 
using detergent is Critical Micelle Concentration (CMC). When the concentration of 
detergent in a solution increases, there is a self-association of molecules with hydrophobic 
ends facing inside and hydrophilic groups outside facing aqueous phase. These self-
associating structures are called micelles and the concentration at which it takes place is 
called CMC. CMC is a characteristic of each detergent and depends on pH, temperature and 
ionic strength (Santos and Ciancaglini, 2000). The principal action of detergent in membrane 
solubilization is to break lipid-lipid, and protein-lipid interaction and this happens best at 
CMC or concentration higher than CMC (Santos and Ciancaglini, 2000). 
1.4.5.1 Types of detergents and their use in native electrophoresis 
Generally detergents can be classified as anionic, non-ionic and amphipathic or 
zwitterions. SDS is the most commonly used anionic detergent but it is not suitable for native 
electrophoresis as besides solubilizing membranes, it disintegrates the enzyme leading to loss 
of activity. Non-ionic detergents are uncharged and considered mild and hence can be used in 
membrane solubilization to isolate mitochondrial complexes with varying degrees of 
association dependent on the kind of detergent used and its concentration. The most 
commonly used non-ionic detergents are Triton X-100, Digitonin and DDM (dodecyl-β-D-
maltoside) which form micelles at very low CMC thus avoiding protein denaturation (Wittig 
and Schägger, 2008). 
Regarding isolation of OXPHOS complexes, these non-ionic detergents behave very 
differently from each other. For example, Digitonin can be used in a very broad 
concentration range (from 0.5 to 8 g/g proteins), as compared to Triton and DDM which 
work in the range of 1-2 g/g proteins (Schägger and Pfeiffer, 2000). Besides this, Digitonin is 
the best candidate for the isolation of supercomplexes due to its milder nature (Reisinger and 
Eichacker, 2008). They can be used to extract OXPHOS complexes from bacteria, yeast and 
mammals, as well as from subcellular fractions or total membranes (Wittig et al., 2006). The 
quantity of detergent required to solubilize membrane proteins vary in the different 
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cells/tissues and optimal solubilisation conditions for each membrane and each membrane 
complex should be experimentally investigated. 
Recently, an interesting modification of classical native PAGE has been proposed. 
Klodmann et al. reported the treatment of the samples with low amounts of SDS before BNE. 
This allowed to destabilize the OXPHOS complexes in sub-complexes in a very defined and 
reproducible manner and to study their internal architectures. SDS was added to the 
mitochondrial Digitonin extracts from Arabidopsis in the range of 0.05-1.0% just before 
BNE loading. By combining with 2D BN-/SDS or 2D BN/BN PAGE, the authors clearly 
demonstrated the variable effect of SDS on the OXPHOS complexes. As an example, at 
0.2% SDS concentration, the ATP synthase complex dissociated in to F0 and F1. At 0.3% F0 
even dissociated in to a sub-complex composed of c-ring (Klodmann et al., 2011). 
1.4.5.2 Non gradient native electrophoresis 
As discussed in previous sections, BNE and hr CNE had proven to be very powerful 
and efficient techniques to detect, isolate, analyze and characterize the OXPHOS complexes. 
But still these methods do not allow to properly resolve mitochondrial proteins other than the 
OXPHOS complexes, such as DLDH (dihydrolipoamide dehydrogenase) and Hsp60 (a heat 
shock protein that is responsible for transportation and refolding of protein from cytoplasm to 
mitochondrial matrix) (Yan and Forster, 2009). Using rat brain mitochondria as a model with 
a non gradient gel of 8%, Yan et al. were able to resolve both the OXPHOS system and the 
DLDH and Hsp60 complexes, demonstrating that this method is an efficient technique (Yan 
and Forster, 2009). 
 
 
 
 
 
 
 
 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aims and objectives 
 
43 
 
2. Aims and objectives 
Based on the introduction of ectopic F0F1 ATP synthase and its well documented role in 
mediating HDL endocytosis, following aims and objectives were laid down: 
A. Proteomic characterization of ectopic F0F1 ATP synthase from rat liver plasma 
membranes to define its molecular mass, subunit composition and localization in 
hepatocytes 
 Preparation of plasma membranes and mitochondria from rat liver 
 Preparation of apical and basolateral fractions from plasma membranes 
 Detergent extraction of OXPHOS complexes, BNE, hr CNE, in-gel activity staining, 
native immunoblotting 
 Mass spectrometric analysis of mitochondrial and ectopic F0F1 ATP synthase 
 
B. Immunofluorescence studies of ectopic F0F1 ATP synthase in HeLa cells: role of 
cholesterol in mediating translocation of β subunit and IF1 from mitochondria to cell 
surface  
 Confocal microscopy of F0F1 ATP synthase subunits ( , OSCP and IF1) in permeabilized 
and non-permeabilized cells  
 Confocal microscopy of flotillin, a lipid raft marker, in permeabilized and non-
permeabilized cells  
 Extracellular ATP synthesis  
 Cholesterol loading followed by confocal  and electrophoretic analyses 
Objective A had been performed in Dept. of Pharmacology, University of Padova in 
collaboration with Prof. Dr. Giovanna Lippe, Dept. of Food Science and Technology, 
University of Udine, Italy. 
Objective B had been performed at Dept. of Veterinary Basic Science, Royal Veterinary 
College, University of London, UK under the guidance of Dr. Michelangelo Campanella. 
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3. Methods 
All animals used in our experiments were harvested and killed at the Animal House 
of the Department of Pharmaceutical and Pharmacological Sciences, University of Padova 
according to the provisions of the European Community Council Directive (n. 86/609/CEE) 
and of the Italian legislation (D.L.vo 116/92). 
3.1 Preparation of mitochondria from rat liver 
Male rats (Sprague Dawley), with a mean weight of 300-350 g, were chosen. Liver 
was removed from the abdominal cavity of anaesthetized animal and kept in the 
homogenization buffer (HM) containing 0.25 M sucrose, 10 mM Tris/HCl, 0.1 mM EDTA 
pH 7.4 (Nicolli et al., 1996). Briefly, liver was chopped in small pieces and washed 3-4 times 
using HM to remove as much blood as possible. Tissue pieces were homogenized in 40-60 
ml/liver of HM in a pre-cooled motor driven glass-teflon homogenizer using 6-7 strokes. 
Homogenate was centrifuged at 1000 g, 10 min in Beckman JA Avanti series refrigerated 
centrifuge using JA 25.50 Beckman rotor and the supernatant was centrifuged again 10 min 
at 7000 g using the same rotor. Mitochondria were re-suspended in 30 ml HM and re-
centrifuged 10 min at 7000 g. The final pellet was re-suspended in minimum quantity of HM 
and stored in aliquots at -20ᵒC. Protein content was quantified using Lowry method or BCA 
method.  
3.2 Preparation of mitochondria from mouse heart 
Mouse heart mitochondria were isolated in a buffer containing 225 mM mannitol, 75 
mM sucrose, 10 mM HEPES, 1 mM EGTA, pH 7.4 (Isolation buffer A, IB A) (Nicolli et al., 
1996). Briefly, tissue was cut in small pieces and washed several times with IB A to 
eliminate blood as much as possible. Tissue pieces were then transferred to a pre cooled 
motor driven glass-teflon homogenizer and 1 ml of IB A was added. Tissue was 
homogenized using 8-10 strokes taking care to avoid foam and heat formation. This step was 
of fundamental importance as it defines the quality of preparation which finally decides the 
enzyme activity. Homogenized tissue was mixed with 6 ml of IB A supplemented with 0.2% 
BSA (IB B) and centrifuged at 500 g, 10 min (to remove unbroken cells or debris) using 
Beckman JA Avanti series refrigerated centrifuge and 25.50 JA Beckman rotor. The 
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supernatant was filtered through a net (150 μm mesh) and centrifuged at 10000 g, 10 min 
using the same rotor so as to pellet down the mitochondria. Mitochondrial pellet was 
resuspended in 2-3 ml of IB B and centrifuged again 6 min at 75000 g. Mitochondria were 
spun down, after washing the pellet in IB A, 6 min at 7500 g. All the operations were carried 
out at 4ᵒC. Protein content was quantified using BCA method and mitochondrial aliquots 
were stored in -20ᵒC. The same process was used to isolate mitochondria from KO mouse. 
Expected yield from each preparation (2 hearts) was around 2-2.5 mg. 
3.3 Preparation of plasma membrane from rat liver 
3.3.1 Method A (PM separated from mitochondrial fraction) 
Male rats (Sprague Dawley), with a mean weight of 300-350 g, were chosen. Liver 
was removed from the abdominal cavity, weighed (10-12 g) and kept in the cool 
homogenizer buffer (0.25 M Sucrose, 10 mM HEPES, 0.2 mM CaCl2, pH 7.4, HM1). Plasma 
membranes were isolated according to (Van Amelsvoort et al., 1978). Briefly, liver was 
chopped and connective tissue was discarded. Tissue was washed 3-4 times using HM1 so as 
to remove blood as much as possible. Tissue pieces were suspended in 20-25 ml of 
HM1/liver and homogenized using a pre-cooled motor driven glass-teflon homogenizer (6-8 
strokes) to minimize heating of the samples. Homogenate was diluted to a final volume of 75 
ml/liver using HM1 supplemented with 1 mM EDTA and centrifuged at 1000 g, 10 min 
using Beckman JA Avanti series refrigerated centrifuge and JA 25.50 Beckman rotor. 
Supernatant was separated and centrifuged at 25000 g, 30 min using the same rotor. The 
peripheral ring of the pellet (white fluffy pellet) contains essentially microsomes and plasma 
membranes which were removed cautiously using Pasteur pipette and collected in a test tube. 
The test tube containing some mitochondria as contaminant was left 10 min in ice to allow 
the sedimentation of heavier mitochondria under gravity. The fluffy upper phase, diluted to 7 
ml with  HM1 was homogenized and layered on the top of a discontinuous sucrose density 
gradient composed of 7 ml and 8 ml of 20% and 39% sucrose in 10 mM HEPES, pH 7.4 
respectively. The gradients were prepared in advance and kept at 4ᵒC. The gradients were 
spun at 50000 g, 150 min using Beckman Ultra Centrifuge L70 and 50.2 Ti Beckman rotor. 
Plasma membranes were recovered at the interphase of heavy and light sucrose using a 
Pasteur pipette. The interphase was diluted 3 times with HM1 and recovered by 
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centrifugation at 70000 g, 40 min using 70.1 Ti Beckman rotor. Pellets enriched of plasma 
membranes (PMA) were re-suspended in a minimal volume of HM1, divided in aliquots and 
stored at -80ᵒC. Protein content was quantified using Lowry or BCA method. All the 
operations were carried at 4ᵒC. The recovery of PM A from one liver was 6-7 mg on average. 
3.3.2 Method B (PM separated from nuclear fraction) 
Plasma membranes were isolated from rat liver (Sprague Dawley, 300-350 g) in a 
homogenization medium (HM2) containing 0.25 M Sucrose, 1 mM MgCl2, 10 mM Tris HCl, 
pH 7.4 according to (Harris et al., 2006) with some little modifications. Briefly, liver (10-12 
g) was chopped, connective tissue removed and the small pieces of liver were washed for 3-4 
times with HM2. Tissue pieces were suspended in HM2 (4 ml/g of the liver weight) and 
homogenized using 30 strokes of pre-cooled motor driven glass-teflon homogenizer. The 
homogenate was filtered using a nylon net (790 μm mesh size) and diluted with HM2 (5 ml/g 
of the liver weight). The diluted homogenate was centrifuged 5 min at 300 g in a refrigerated 
bench top centrifuge to pellet down unbroken cells. 50 ml aliquots of the supernatant were re-
centrifuged 10 min at 1500 g in Beckman JA Avanti series refrigerated centrifuge and JA 
25.50 Beckman rotor to pellet down nuclei and the plasma membranes which collapse over it 
leaving mitochondria and other organelles in the supernatant. The pellet was re-suspended in 
half volume of HM2 respect to the initial and supplemented with 50 ml of dense sucrose 
solution (2 M Sucrose, 1 mM MgCl2, 10 mM Tris HCl, pH 7.4). The suspension was divided 
in 25 ml aliquots each, overlaid with 1.5 ml of HM2 and subjected to ultracentrifugation at 
113000 g for 1 h using Beckman Ultracentrifuge L70 and 50.2 Ti rotor. Plasma membrane 
sheets were collected at the interface, diluted four times with HM2 buffer and recovered by 
centrifugation 10 min at 8000 g. The pellet, PMB, was suspended in a small volume of HM2 
and stored in aliquots at -80ᵒC. All the operations were carried out at 4ᵒC. 
Sometimes a further purification of PMB was carried out. Briefly, PMB (1-2 mg) was 
homogenized with 4-5 ml of HM2 and over laid on a discontinuous sucrose density gradient 
of 20% and 39% sucrose buffered with 10 mM Tris/HCl, pH 7.4 and centrifuged at 50000 g 
for 2 h using Beckman Ultracentrifuge L70 and 70.1 Ti rotor. The purified plasma 
membranes were collected from the interphase and, after four times dilution, recovered by 
ultracentrifugation for 40 min at 70000 g. The new pellet (PMBp) was suspended in a small 
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volume of HM2 and stored in aliquots at -80ᵒC. Protein content was quantified using Lowry 
or BCA method. 
3.3.3 Preparation of basolateral and apical membranes 
Apical and basolateral membranes were prepared according to the (Harris et al., 
2006). 2-2.5 mg of PMB proteins were homogenized using 30 vigorous strokes of a pre-
cooled tight fitting Potter-Elvehjem homogenizer in suspension buffer containing 0.25 M 
sucrose, 10 mM Tris-HCl, pH 7.4 (SB). The suspension was laid over discontinuous gradient 
of 44%, 39% and 34% sucrose in SB and spun at 200000 g for 3 h using Beckman 
Ultracentrifuge L70 and 70.1 Ti rotor. Apical membranes were collected at the interface 
between 34% and 39% sucrose, while basolateral membranes were collected from the 
interphase of 39% and 44% sucrose. After dilution with 2 volumes of SB, membranes were 
harvested by centrifugation at 200000 g for 30 min. All the operations were carried out at 
4ᵒC. Protein content was quantified using Lowry or BCA method. 
 3.4 Cell Culture  
All the experiments of this thesis were carried out using HeLa cell line (Human 
Cervical Adenocarcinoma Cells). HeLa cells were grown in culture medium composed of 
DMEM (Gibco
TM
 41966, Life technologies, Inc) supplemented with 10% Foetal Bovine 
Serum (FBS-Gibco
TM
 10106-185, Life Technologies, Inc), 50 U/ml Penicillin and 25 μg/ml 
Streptomycin (Campanella et al., 2008). Cells were grown in T-75 250 ml Falcon flasks and 
incubated at 37ᵒC in a 5% CO2 humidified incubator. Once the cells have reached to 60-70% 
confluency, they were split and plated again on 100 x 15 mm Petridishes or on 6 well plates 
as required. To split, cells were first washed twice with PBS (Gibco 10010-015, Life 
Technologies, Inc) followed by trypsinization for 5 min at 37ᵒC, 5% CO2 using 0.5% 
Trypsin-EDTA in Phenol red (Gibco
TM
 25200-072, Life Technologies, Inc). To stop the 
action of trypsin, DMEM was added and then cells were centrifuged at 1200 g, 5 min, 
resuspended in about 4 ml of DMEM and re-plated using 50-200 μl of cell suspension as 
required for the experiment. The cells were split every 3-4 days so as to maintain their 
morphology (Campanella et al., 2009). 
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3.4.1 Cholesterol loading  
Cells were loaded with cholesterol (20 μg/ml) (Wang et al., 2006) for a period of 2 
and 4 h at 37ᵒC, 5% CO2 prior to preparation of mitochondria and plasma membranes or 
preparation of slides for confocal microscopy. 
3.4.2 Preparation of mitochondria and plasma membranes from HeLa cells  
Mitochondria and plasma membranes were prepared from HeLa cells according to 
Nature’s protocol with little modifications (Frezza et al., 2007). Cells were seeded in two 
Petri-dishes, 2 days prior to the experiment so as to get a good number of cells. Cells were 
washed twice with ice cold PBS and then scraped using cell scrapper, collecting them in 15 
ml Falcon tubes, finally the plates were washed with minimum volume of PBS so as to scrap 
the remaining cells attached to it. Cell suspension was centrifuged at 600 g, 10 min to pellet 
down the cells, supernatant was discarded and cells were re-suspended in 2-3 ml of isolation 
buffer (0.2 M Sucrose, 10 mM Tris-MOPS, 1 mM EGTA, pH 7.4, IB). Cells were 
homogenized using a glass porter with 60 vigorous strokes (20 each time with a gap of 20 
seconds so as to minimize the heating) followed by the centrifugation at 600 g, 10 min to 
pellet down the unbroken cells. The supernatant was re-centrifuged at 7000 g, 10 min so as to 
collect the mitochondria leaving plasma membranes and other organelles in suspension. 
Mitochondrial pellet was re-suspended in IB and harvested at 8000 g, 10 min. The 
supernatant obtained after centrifugation at 7000 g was collected and centrifuged at 100000 
g, 45 min at 4ᵒC using Beckman Ultracentrifuge L70 and 70.1 Ti rotor to obtain plasma 
membranes (Van Amelsvoort et al., 1978). The membrane pellet was collected and re-
suspended in about 100 μl of IB. All the operations were carried out at 4ᵒC. Mitochondrial 
and plasma membrane proteins were quantified using BCA protein assay kit (23225 Pierce 
Thermo Scientific). 
3.5 Detergent extraction 
Detergent extraction of mitochondria and plasma membranes were performed 
according to (Giorgio et al., 2010;  Wittig et al., 2006;  Zerbetto et al., 1997) with little 
modifications. Mitochondrial and plasma membrane proteins (500 μg) were centrifuged at 
25000 g and 100000 g respectively for 20 min at 4ᵒC using Beckman Ultracentrifuge L70 
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and 70.1 Ti rotor. Pellets were re-suspended in 50 μl of solubilization buffer containing 50 
mM imidazole, 500 mM 6-aminohexanoic acid, 1 mM EDTA, pH 7 at 4ᵒC (Table 7) 
followed by the addition of the non-ionic detergents as described below.  
Triton 100-X- 2.5 μl and 5 μl of TritonX-100, diluted 1:5, were added to obtain a 0.5% and 
1% final concentration, respectively. 
Lauryl Maltoside (DDM)- 15 μl of 10% DDM, always freshly prepared before use were 
added to obtain a final ratio of 3 g/g of protein. 
Digitonin- 2.5, 5 and 10 μl of 10% Digitonin, freshly prepared by boiling it for 5 min at 
90°C, were added to obtain 0.5, 1 and 2 g/g of membrane or mitochondrial proteins 
respectively. 
The mitochondrial samples supplemented with detergents were incubated 5 min at 4°C, while 
plasma membranes were incubated 20 min at 37°C. The suspensions were re-centrifuged 30 
min at 4ᵒC, 100000 g using the same rotor to pellet down the unsolubilized membranes. 
Extracts were collected as supernatants and stored at -80ᵒC if not used immediately. 
3.6 Blue native electrophoresis 
Blue native electrophoresis (BNE) was performed according to Nature’s protocol 
(Wittig et al., 2006) and (Zerbetto et al., 1997) with little modifications. The whole process 
comprises of following steps: 
3.6.1 Gel casting 
Acrylamide-bisacrylamide mixture was composed of 48 g of acrylamide and 1.5 g of 
bisacrylamide in 100 ml distilled water (AB3-mix). Unless otherwise stated, this solution was 
used to prepare native gradient gels throughout the experiments. Gel buffer (3X) was 
composed of 75 mM Imidazole, 1.5 M 6-aminohexanoic acid pH 7; 10% ammonium 
persulfate (APS) was freshly prepared. The amount of each reagent/ solution required to cast 
one gel (1 X 70 X 82 mm) is listed in Table 5. To resolve the super-complexes of the 
respiratory chain, 4-11% gradient gel was preferred. 
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Composition 
Stacking gel Resolving gel 
3% 4% 4% 5% 11% 
AB3-mix 0.29 ml 0.39 ml 0.78 ml 0.98 ml 1.98 ml 
Gel buffer 1.66 ml 1.66 ml 3.3 ml 3.3 ml 3 ml 
Glycerol - - - - 1.8 g 
TEMED 4 μl 4 μl 4.4 μl 4.4 μl 4 μl 
Water qs 5 ml 5 ml 10 ml 10 ml 9 ml 
One gel 1 ml 1 ml 3 ml 3 ml 2.6 ml 
APS (10%) 15 μl 15 μl 26 μl 26 μl 15 μl 
Table 5 Composition for stacking and resolving gel to prepare gradient gels for 1 mm plate thickness 
3.6.2 Electrophoresis conditions 
BNE used 7.5 mM imidazole and 500 mM Tricine, pH 7  0.02% Coomassie Blue G-
250 as cathode buffer and 25 mM imidazole, pH 7 as anode buffer. The most important point 
was to conduct all the operations including pH titration at 4ᵒC. Loading buffer for BNE was 
prepared using 5% Coomassie Blue G-250 in 1 M 6-Aminocaproic Acid. Coomassie Blue G-
250 has low water solubility so a long vortex agitation was necessary. Prior to use, the 
solution was centrifuged well to spin down the residual un-dissolved crystals that might give 
smear along the lanes of the gel. 1 μl of loading buffer was added to 15 μl of the detergent 
extract.  
Electrophoresis was performed at 4-7ᵒC so as to avoid the inactivation of enzymes. 
The initial voltage was kept constant at 180 V (corresponding current- 16 mA) until the dye 
front had reached almost half of the total desired running distance. After this, the blue 
cathode buffer was changed to colorless cathode buffer and the voltage was increased up to 
250 V for the remaining part of the run. Electrophoresis was stopped after 2-3 h, following 
which the gel was either incubated for in-gel activity staining or native immuno-blotting. 
3.7 High resolution clear native electrophoresis (hr CNE) 
The electrophoresis was performed according to (Wittig et al., 2007) with little 
modifications. The procedures were almost similar to that of BNE with little modifications. 
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The cathode buffer contained 50 mM Tricine, 7.5 mM imidazole supplemented with 0.05% 
of Triton and 0.05% DOC to facilitate the movement of proteins. The anode buffer was 
similar to that of BNE and contained 25 mM imidazole, pH 7 at 4ᵒC. There was no change of 
cathode buffer as in BNE after 30 min of run. The loading dye contained 0.1% Ponceau S in 
50% glycerol and each 10 μl of detergent extract was supplemented with 1 μl of loading dye. 
All other procedures including electrophoretic conditions are similar to that of BNE. 
3.8 SDS PAGE  
SDS PAGE was performed according to Laemmli (1970). Briefly, 5 μg of 
mitochondrial and 40 μg of plasma membrane proteins were denatured using Laemmli buffer 
(0.125 M Tris/HCl, 4% SDS, 10% β-mercaptoethanol, 0.004% bromophenol blue, pH 6.8) 
and subjected to 10% or 12% polyacrylamide gel electrophoresis depending on the molecular 
weight of the proteins to be analyzed, using running buffer composed of 25 mM Tris, 192 
mM Glycine and 0.1% SDS. The electrophoresis was performed using mini gel apparatus 
(Miniprotean BioRad) at a constant current of 16 mA for 2 h at room temperature.  
3.9 Western blotting  
3.9.1 Denaturing immuno-blotting 
Following SDS-PAGE, proteins were transferred to nitrocellulose membrane at a 
constant current of 400 mA for 1 h using the transfer buffer containing 25 mM Tris, 192 mM 
Glycine, 0.1% SDS and 20% Methanol (Table 6). The membrane was blocked using 3% 
non-fat dry milk (BioRad) in PBS-Tween for 1.5 h and incubated overnight in blocking 
solution with antibodies listed in Table 7 at 4ᵒC. Membranes were washed with PBS-Tween 
(3x 15 min) and labeled using horse raddish peroxidase conjugated secondary antibodies 
(Sigma and Dako) in blocking solution for 1.5 h. The blots were washed as before and 
developed using ECL Plus western blotting substrate (Amersham), imaged using Versadoc 
(BioRad) and quantified using Quantity one (BioRad). The band intensities were normalized 
to loading control so as to minimize the error due to protein loading in the wells where  
required. 
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3.9.2 Native immuno-blotting 
Following BNE or hr CNE, proteins were transferred to nitrocellulose membrane to 
perform native immuno-blotting. The only difference between the denaturing and native 
immuno-blotting was the absence of negative charge on the surface of proteins. To assist the 
transfer, the native gels were pre incubated for 1 h in 25 mM Tris, 192 mM Glycine and 
0.1% SDS and then blotted on nitrocellulose membrane using a transfer buffer without SDS 
containing 25 mM Tris, 192 mM Glycine and 10% Methanol (Table 6) at 400 mA constant 
current for 70 min. Following protein transfer, membrane was processed as discussed above. 
Buffer type Trizma Base Glycine SDS Methanol 
Transfer buffer, SDS PAGE 25 mM 192 mM 0.1% 20% 
Transfer buffer, Native PAGE 25 mM 192 mM - 10% 
Table 6 Composition of running and transfer buffers for SDS and Native PAGE 
Antigen Clone Dilution  Source  
CV F1 α/β Polyclonal  1:1000 In-house 
C IV (COX) Monoclonal 1:1000 Abcam (ab14744) 
C III Polyclonal 1:1000 In-house 
C II Polyclonal 1:1000 In-house 
C I  Polyclonal 1:1000 In-house 
ATP5A, anti α Monoclonal 1:1000 Abcam (ab110273) 
ATP5B, anti β Monoclonal 1:2000 Abcam (ab14730) 
ATP5O, OSCP Monoclonal 1:1000 Abcam (ab110276) 
NTCP Polyclonal 1:1000 
Santa Cruz Biotech., 
sc-98484 
BSEP Polyclonal 1:1000 
Santa Cruz Biotech., 
sc-25571 
Flotillin 1 Polyclonal 1:2000 Sigma, F1180 
Clathrin heavy 
chain Monoclonal 1:1000 Sigma, C1860 
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TERA/vcp97 Polyclonal 1:1000 
Thermo scientific, 
PA5-14786 
TOM 20 Polyclonal 1:1000 
Santa Cruz Biotech, 
FL145 
VDAC Polyclonal 1:1000 
Santa Cruz Biotech, sc-
98708 
IF1  Monoclonal  Abcam (57694) 
Table 7 List of primary antibodies and their dilution for Western blotting 
3.10 In-gel activity staining of OXPHOS complexes 
In-gel staining of the complexes was done according to (Zerbetto et al., 1997) and 
(Wittig et al., 2007). hr CNE was preferred more over BNE for in-gel activity staining to 
avoid the interference of Coomassie Blue with the activity of the complexes. Immediately 
after native electrophoresis, gels were subjected to native staining of the individual 
complexes as described below. The conditions for the activity staining for all the complexes 
have been outlined in Table 4. 
3.10.1 Complex I 
In-gel NADH reductase activity of complex I was determined by incubating the 
native gel slices in 2 mM Tris/HCl pH 7.4 supplemented with 0.1 mg/ml NADH and 2.5 
mg/ml NTB (nitrotetrazolium blue) at room temperature. The saturating violet color of the 
enzymatic reaction for mitochondrial complex I was observed in half hour but for ectopic 
complex I activity, a further incubation of 1 h was required. 
3.10.2 Complex II 
In-gel succinic dehydrogenase (SDH) activity was determined by incubating the 
native gel slices in 4.5 mM EDTA, 10 mM KCN, 0.2 mM phenazine metha-sulfate (PMS), 
84 mM succinic acid supplemented with 50 mM NBT in 1.5 mM phosphate buffer, pH 7.4 at 
room temperature. The saturating violet color for the mitochondrial complex II was observed 
after 1 h but for ectopic complex II, incubation was continued overnight. 
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3.10.3 Complex IV 
In-gel cytochrome c oxidase (COX) activity was determined by incubating the native 
gel slices with the buffer containing 5 mg mg 3,3’-di-aminobenzidine tetrahydrochloride 
(DAB) dissolved  in 9 ml phosphate buffer (0.05 M, pH 7.4), 1 ml catalase (20 μg/ml) 
supplemented with 10 mg cytochrome c and  750 mg sucrose. The saturating red color for the 
mitochondrial complex IV was observed after 1 h but for ectopic complex IV, overnight 
incubation was required. 
3.10.4 Complex V 
ATP hydrolysis assay of complex V (ectopic and mitochondrial) was analyzed by 
incubating the native gel slices in a buffer containing 35 mM Tris, 270 mM Glycine 
supplemented with 14 mM MgSO4, 0.2% Pb(NO3)2 and 8 mM ATP, pH 7.8 at room 
temperature. For ectopic F0F1 ATPase, incubation at 37ᵒC was required for a quantitative 
measurement of enzyme activity. The white lead phosphate generated by the reaction of Pi 
and Pb(NO3)2 was imaged using Versadoc (BioRad) under the white light and quantified 
using Quantity one (BioRad). 
3.11 Immuno-precipitation  
Two different approaches were used to perform the immuno-precipitation of ectopic 
F0F1 ATP synthase from plasma membranes: 
3.11.1 Immuno-precipitation of the whole complex 
Detergent extraction using 1 g/g digitonin was performed as in section 3.5. 50 μl of 
digitonin extracts were incubated with anti F0F1 monoclonal antibodies covalently linked to 
protein G-Agarose beads (MS501 Immunocapture kit, Mitoscience) in a ratio of 20 μl of 
conjugated beads per mg of membrane protein according to manufacturer’s instructions. 
Samples were incubated overnight under wheel rotation at 4ᵒC. After centrifugation (500 g, 5 
min), the beads were washed twice with 0.05% DDM in PBS and the pellet was dissolved in 
Laemmli buffer at 95ᵒC and subjected to 12% SDS PAGE and Western blotting as described 
in section 3.8 and 3.9. Membrane was then probed with monoclonal antibodies against  
subunit and polyclonal anti TERA. 
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3.11.2 Immune-precipitation of individual subunits (α subunit and TERA) from plasma 
membranes 
S. aureus protein A-sepharose® 4B (Sigma) beads (for TERA) and protein G-
sepharose® Fast flow (for α subunit) were spun at 10000 g, 20 seconds to remove ethanol 
and then washed 3 times with 50 mM Tris/HCl and finally re-suspended in the same volume 
as that of ethanol removed. 30 µl of S. aureus protein A-sepharose
®
 4B were coupled with 7 
µg of anti-TERA antibody or 30 µl of protein G-sepharose® Fast flow (for α subunit) were 
coupled with 4 μg of anti α subunit antibody in IP buffer (15mM Tris, 2 mM EDTA, 0.5% 
Triton X-100 (v/v), 0.005% BSA (w/v) and 0.25% SDS (v/v)) and incubated for 2 h at 4°C. 
In both cases nonimmune antibody was coupled with the respective beads in IP buffer. 0.5 
mg PMB, solubilized and precleared in IP buffer, was added and incubated overnight at 4°C. 
IP samples were centrifuged at 10000 g for 20 seconds and then pellet was washed with 1 ml 
IP buffer 3 times. To the final pellet 30 μl of pre-heated Laemmli buffer was added, mixed 
well and heated at 95ᵒC for 5 min followed by centrifugation for 1 min. Supernatant was 
loaded on 12% SDS-PAGE followed by immunoblotting.  
Preclearing of PMB samples  
In order to avoid nonspecific binding PMB samples were precleared by incubating 
0.5 mg protein with 60 μl of beads, 0.5 μl of Anti Protease and 500 μl of IP buffer under 
wheel rotation for 1 h at 4ᵒC. Samples were centrifuged at 10000 g for 20 seconds and 
supernatant was retained.  
3.12 Mass spectrometric analyses of mitochondrial and ectopic F0F1 ATP synthase  
After the separation of proteins by hr CNE, followed by in-gel ATPase staining, the 
bands were excised and destained upon incubation overnight with 10% acetic acid. In-gel 
digestion was performed using following steps as previously described in (Wilm et al., 1996).  
3.12.1 Reduction  
Destained gel pieces were swelled in 10 mM dithiotreitol 0.1 M NH4HCO3 and 
incubated at 56ᵒC to reduce the proteins following which they were spun down to remove 
excess liquid. Gel pieces were shrinked again with acetonitrile. 
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3.12.2 Alkylation 
After reduction proteins were alkylated using 55 mM iodoacetamide/0.1 M NH4CO3 
by incubating the gel pieces for 20 min at room temperature in dark. Iodoacetamide was 
removed and gel pieces were washed with 150-200 μl 0.1 M NH4CO3 for 15 min following 
which liquid was removed and gel particles were shrinked again using acetonitrile. After this 
gel particles were dried in Heto Vacuum centrifuge (Heto, ThermoFisher Scientific) 
3.12.3 In-gel digestion  
Gel particles were rehydrated using digestion buffer containing 50 mM NH4HCO3 
and 12.5 ng/μl of porcine trypsin (modified sequencing grade; Promega, Madison, WI, USA) 
at 4ᵒC for 30-45 min. More buffers was added if required to cover the gel pieces and then 
incubated overnight at 37ᵒC. The supernatants were then transferred to other tubes and 
residual tryptic peptides were extracted upon incubation of gel spots with 25 mM NH4HCO3 
at 37 °C for 15 min followed by shrinking of gel pieces with acetonitrile, and then upon 
incubation with 5% (v⁄v) formic acid at 37 °C for 15 min followed by shrinking with 
acetonitrile. The extracts were combined with the primary supernatant and dried in a Heto 
Vacuum centrifuge (Heto, ThermoFisher Scientific). 
3.12.4 LC-MS/MS analysis 
Protein digests were then resuspended in 0.1% formic acid and analysed by LC-
MS/MS. MS analysis was performed on a LTQ-Orbitrap XL mass spectrometer 
(ThermoFisher Scientific) coupled with an on-line nano-HPLC Ultimate 3000 (Dionex, 
ThermoFisher). Samples were loaded onto 10 cm fused silica emitter, 75 μm inner diameter 
(Waters) packed in-house with a Magic C18 AQ 5μm resin (Michrom BioResources, 
Auburn, CA, USA). The samples were separated at a flow rate of 250 nl/min using a gradient 
from 3% B to 40% B in 39 min (solvent A: H2O with 0.1% formic acid; solvent B: 
acetonitrile with 0.1% formic acid). The MS/MS acquisition method was based on a full-scan 
on the Orbitrap with a resolution of 60,000, followed by the isolation for fragmentation of the 
most intense ions (up to ten) in the linear ion-trap. MS/MS data were searched using the 
MASCOT search engine (Matrix Science Ltd., London, UK) against the Rattus sequences of 
the Swiss-Prot database (release 2011_05). The following parameters were used in the 
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MASCOT search: trypsin specificity; maximum number of missed cleavages: 2; fixed 
modification: carbamidomethyl (Cys); variable modifications: oxidation (Met); peptide mass 
tolerance: ± 10 ppm; fragment mass tolerance: ± 0.6 Da; protein mass: unrestricted; mass 
values: monoisotopic. 
3.13 Confocal microscopy  
3.13.1 Cell culture 
For confocal microscopy, cells were seeded on sterile coverslips on 6 well plates 1 
day prior to the experiment so as to reach a confluency of 60%. In short, cells were split as in 
section 3.4 and coverslips were laid with 50 μl of cells suspension supplemented with 2 ml 
of DMEM and incubated at 37ᵒC, 5% CO2. Over-confluency was avoided to have a good 
selection of cells for imaging. Where required cells were loaded with cholesterol (20 μg/ml) 
as explained in section 3.4.1. 
3.13.2 Fixation and permeabilization 
Before fixation cells were washed twice with 1 ml PBS and then fixed by incubating 
the cells with 1 ml 4% PFA (para formaldehyde) under shaking conditions for 15 min 
following which coverslips were washed with 1 ml PBS, 3x5 min at room temperature. Cells 
were either permeabilized by incubating coverslips with 1 ml of 0.1% Triton in PBS for not 
more than 15 min under shaking followed by washing with PBS as above or left non-
permeabilized.  
3.13.3 Blocking and antibody incubation 
Cells were blocked for 1 h using 10% BSA (Sigma) and 3% Goat serum (Gibco
TM
, 
16210-064 Life Technologies, Inc) in PBS following which they were incubated with 
primary antibodies viz. anti β (1:500), anti IF1 (1:500), anti flotillin (1:500) and anti OSCP 
(1:500) in blocking solution for overnight at 4ᵒC. Incubation was done in a custom build 
humidified chamber so as to avoid the drying of antibody solutions. Moreover, each sample 
was incubated with only two antibodies originating from two different sources in order to 
have two different secondary antibodies giving different fluorescence. For controls cells were 
either incubated only with secondary antibodies so as to check for artifact fluorescence or 
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with antibody against β catenin (sc-7963, Santa Cruz, Biotechnology) in both permeabilized 
and non permeabilized conditions. Coverslips were washed with PBS (3x5 min) and then 
incubated with a cocktail of Alexa Fluor conjugated secondary antibody (AF 555 and AF 
488, Invitrogen) in blocking solution (1:500) for 1 h under darkness. Coverslips were washed 
again as before, air dried and mounted on a coverslip using DAPI mounting medium 
(Abcam). 
3.13.4 Imaging 
Confocal imaging was performed using Leica SP5 Confocal microscope. A good field 
of cells was selected first in phase contrast and then was viewed under fluorescence at 40X 
magnification. AF 488 (green) was excited using 488 nm Argon laser, AF 555 (red) was 
excited using 543 nm He-Ne laser and DAPI was viewed using 405 nm blue-violet diode 
laser. At-least 25 cells were selected at random for imaging. The images were quantified 
using LAS-AF Lite and Volocity software. In all the conditions laser power, gain and offset 
were kept constant. 
3.14 Extracellular ATP synthesis measurements  
HeLa cells were plated on coverslips as described in the section 3.4 and flushed with the 
medium containing 200 μM ADP and 2 mM MgCl2 (recording medium, RM) at 37ᵒC in a 
custom built luminometer (Campanella et al., 2008). Basal level was stabilized to 500 
counts/sec and then cells were again flushed with RM supplemented with 20 mM potassium 
phosphate (Pi), 50 μM Luciferin and 6 μg Luciferase. Cells were incubated for 15 min at 
37ᵒC, 5% CO2 either with oligomycin (10 μg/ml) or anti β antibody (1:500) and counts were 
recorded. 
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4. Results  
 Objective A (Proteomic characterization of ectopic F0F1 ATP synthase) 
The first aim of my thesis was to set up the conditions to purify ectopic ATP synthase 
from liver plasma membranes, in order to define the assembly and subunit composition of 
such complex and to discover analogies and differences between ectopic and mitochondrial 
ATP synthase. I started preparing rat liver mitochondria and plasma membranes using the 
method described in the paper of Giorgio et al. (PMA) (Giorgio et al., 2010) and 
subsequently I performed extraction of both protein samples with different mild detergents, 
i.e. dodecylmaltoside, Triton X-100 and digitonin. Native electrophoresis, BNE and hr CNE, 
were used to separate the native complexes and the presence of ATP synthase complexes was 
established by in-gel ATPase activity staining and immunoblotting (Giorgio et al., 2010;  
Zerbetto et al., 1997).  
Later work demonstrated that another preparation method of plasma membranes 
(PMB) was the best one, allowing the mass spectrometry analyses of the ectopic enzyme. 
4.1. BNE and hr CNE of heart and liver mitochondria detergent extracts 
Preliminary experiments have been performed using bovine heart and rat liver 
mitochondria (see Methods) as starting material and DDM and Triton X-100 as detergents. 
BNE was first used for electrophoretic analyses of the extracts. As shown in Figure 4.1 all 
OXPHOS complexes were detected and separated on the gel. While DDM solubilized all the 
OXPHOS complexes, TritonX-100 was more selective for complex V, but in both cases only 
the monomeric form of ATP synthase was revealed. 
Digitonin is a mild detergent normally used to purify mitochondrial OXPHOS 
supercomplexes (Wittig et al., 2008). Figure 4.2 shows BNE, stained with Coomassie Blue 
G 250 and in-gel ATPase activity, of mitochondria from different sources which were 
extracted using 1 g/g digitonin. As expected, in all samples monomeric and dimeric forms of 
the ATP synthase were present, although in slightly different ratio, indicating digitonin as the 
best extracting non-ionic detergent able to preserve the supra-molecular structures of ATP 
synthase (Wittig et al., 2008). 
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Figure 4.1 BNE of bovine heart and rat liver mitochondria displaying various OXPHOS complexes. 
Detergent extraction had been performed using DDM and Triton X-100 and the extracts were separated on 5-
11% gradient native gel. 
 
Figure 4.2 Coomassie-stained BNE and in-gel activity assay of complex V isolated from mitochondria of 
various tissues. Detergent extraction was performed using 1 g/g Digitonin and the extracts were subjected to 5-
11% gradient native gel. Vm and Vd denote monomeric and dimeric form, while F1 the catalytic sector of the 
mitochondrial ATP synthase. 
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To avoid the interference of Coomassie Blue G with in-gel ATPase activity staining (Wittig 
and Schägger, 2008), hr CNE had been experimentally introduced. Figure 4.3 shows a 
characteristic hr CNE pattern of bovine heart and rat liver mitochondria extracted with 
digitonin. Due to the presence of 0.05% Triton X-100 and 0.05% DOC in cathode buffer, the 
technique gave a resolution comparable to BNE separating both the monomeric and dimeric 
forms of ATP synthase (Wittig et al., 2007). As seen during the experiments, the white bands 
of ATPase assay could be visualized much faster than in BNE and more easily quantified.  
 
Figure 4.3 hr CN PAGE of bovine heart and rat liver mitochondria displaying monomeric and dimeric 
form of ATP synthase. 
4.2 Detergent extraction and hr CNE of ectopic ATP synthase from rat liver plasma 
membranes prepared according to method A 
4.2.1 Preliminary studies - choice of detergents and conditions of detergent extraction 
As described in literature (Bae et al., 2004;  Kim et al., 2004) ectopic ATP synthase is 
mainly localized in lipid rafts whose lipid composition is completely different with respect to 
that of the mitochondrial inner membrane. In fact, lipid raft are rich in cholesterol and 
sphingolipids while inner mitochondrial membrane is rich in negative charged cardiolipin 
(Mazzone et al., 2006). This implied that new preliminary extraction experiments were 
necessary.  Work was started by optimizing the choice of detergent and extraction conditions 
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from plasma membranes prepared according to method A (PMA) (see section 3.3.1), using 
in-gel ATPase assays to check the extraction efficiency. Figure 4.4 shows the results 
obtained with the three non-ionic detergents previously used to extract mitochondrial ATP 
synthase. More specifically, Triton X-100 was used at concentrations of 0.5, 1 and 2%, while 
digitonin was used at 1 and 2 g/g and compared with 1g/g of DDM. Moreover, extraction 
from  plasma membranes was carried out at 37°C (Kim et al., 2006) whereas mitochondria 
were always extracted at 4°C. 
 
Figure 4.4 Detergent extraction, hr CNE and in-gel ATPase staining of ecto-F0F1 complexes extracted 
from PMA and mitochondria.  
Digitonin was the only detergent able to extract active complexes (ecto-F0F1) having almost 
the same molecular mass as the F0F1 monomers extracted from mitochondria, thus suggesting 
that the ectopic ATP synthase has the same subunit composition of the mitochondrial 
complex. On the other hand, a faint white band was observed in all extracts just below the 
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ecto-F0F1 band with ATPase activity that could be due to partial degradation of the enzyme. 
Moreover, the recovery of ecto-F0F1 was not reproducible (data not shown) that could be 
assigned both to a variable recovery of plasma membranes in the crude preparation by 
method A and/or to a variable content of ecto-F0F1 complexes in plasma membranes, both 
factors  affecting the efficiency of digitonin extraction.  
4.2.2 1D BN/ hr CNE-2D SDS PAGE and Western blotting of ecto-F0F1 extracted from 
PMA 
Because the content of ecto-F0F1 was very low and variable in PMA, Coomassie 
staining was not sufficiently sensitive to detect its electrophoretic native band. To check the 
presence of α/β subunits in the ecto-F0F1 bands, two dimensional Western blotting was used. 
First dimensional hr CNE or BNE was performed using digitonin extracts of plasma 
membranes and the bands of ecto-F0F1 were excised and incubated with Laemmli buffer for 
30 minutes. The excised bands were then loaded on a second dimensional 12% SDS PAGE, 
followed by Western blotting against α/β subunits. Mitochondrial complex V bands were 
used for comparison. As shown in Figures 4.5 and 4.6, clear bands from both bovine heart 
and rat liver mitochondria can be seen, while in plasma membranes samples neither hr CNE 
nor BNE-SDS PAGE gave any bands in both Coomassie staining and immunoblotting 
against α/β subunits, implying that both methods are not sensitive enough to detect small 
quantities of ecto-F0F1. 
 
Figure 4.5 1D hr CNE, 2D SDS PAGE and Western blotting of PMA and mitochondria from rat liver and 
bovine heart.  
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Figure 4.6 1D BNE, 2D SDS PAGE and Western blotting of PMA and mitochondria from  rat liver and 
bovine heart.  
4.3 Characterization of ecto-F0F1 complexes obtained from plasma membranes 
prepared by method A and B (PMA and PMB) 
To overcome the low and variable recovery of ecto-F0F1 complexes obtained by 
extraction of PMA, a new method of plasma membrane separation (method B) was used 
based on a markedly different approach. In the previous Method A, plasma membranes 
(PMA) were obtained from the subcellular fraction containing microsomes and plasma 
membranes by a 3 h centrifugation on a discontinuous 20/39% sucrose gradient, while in 
method B plasma membranes collapsed over the nuclei were separated as floating sheets by 
isopycnic centrifugation using 2 M sucrose (PMB). Figure 4.7 (A and B) shows that both the 
methods yielded active complexes but membranes prepared by method B gave a higher yield 
of ecto-F0F1 complexes in terms of recovery. Moreover, native immunoblotting against α/β 
subunits was run, which consists in direct protein transfer from hr CNE to nitrocellulose 
membrane (see section 3.11.2) instead of 2D SDS PAGE and Western blotting, in the attempt 
to increase sensitivity. This approach allowed to clearly confirm the presence of α/β subunits 
in the band of ecto-F0F1. Moreover, by measuring the ratio between activity-stained ATPase 
bands and blotted F1 α/β bands, the specific activity of ecto-F0F1 extracted from PMB was 
almost 40% higher as compared to that obtained from method A. Another important 
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observation was the absence of dimers in the extracts of plasma membranes in contrast to the 
mitochondrial extracts. 
 
Figure 4.7 hr CNE, in-gel ATPase assay (Panel A) and native immunoblotting (Panel B) of ecto-F0F1 
complexes extracted from plasma membranes prepared by method A (PMA) and method B (PMB). 
Plasma membrane and mitochondrial proteins (500 μg) were extracted using 1 g/g of digitonin 
(detergent/protein ratio) at 37ᵒC and 4ᵒC, respectively. Extracts were loaded (5 μl for mitochondria and 20 μl for 
plasma membranes) on hr CN PAGE and subjected to both in-gel ATPase activity staining and immunoblotting 
against polyAb α/β subunits. Vm and Vd denote monomeric and dimeric form of the mitochondrial enzyme. 
Panel C denotes the comparison of specific activities of ecto- F0F1 ATPase, calculated by measuring the ratio of 
intensities of ATPase band and blotted F1 α/β band. The ratios obtained are representative of two independent 
experiments. 
A closer look at the ATPase activity and blotting revealed that the ectopic complex 
obtained from method A was partially degraded due to presence of a faint second band. This 
result was consistent with those obtained in Figure 4.7 and could be attributed to the multi-
step procedure of preparation which might degrade the complex. On the other hand more 
simple and less time-consuming method B yielded a complete complex without any 
degradation. Based on these results it was concluded that method B was the method of choice 
for the preparation of ecto-F0F1 complexes and hence was used in the subsequent 
experiments. Moreover, when PMB was double purified using a 20/39% sucrose density 
gradient centrifugation and subjected to digitonin extraction, hr CNE, in-gel ATPase staining 
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and immunoblotting, the ectopic enzyme had a similar ATPase activity and immunoreactivity 
toward the F1 α/β antibody as the enzyme directly extracted from PMB (Figure 4.8). 
 
Figure 4.8 hr CNE, in-gel ATPase assay and native immunoblotting of ecto-F0F1 complexes extracted 
from double purified plasma membranes prepared by method B and mitochondria.  
All the above results supported the conclusion that ecto-F0F1 complexes extracted 
from plasma membranes have a similar molecular mass as that of mitochondrial complexes 
and method B was the method of choice for their extraction in terms of high recovery, high 
specific activity and absence of degradation products. 
4.4 Detergent and temperature sensitivity of ectopic and mitochondrial F0F1 complexes  
To exclude that the F0F1 complexes detected in plasma membranes did not simply 
reflect a mitochondrial contamination, the dose and temperature dependency of digitonin 
extraction from mitochondria and PMB was compared, since such dependency could be 
related to lipid composition which is quite different in mitochondria and plasma membranes 
(Mazzone et al., 2006). As evidenced by in-gel ATPase staining of hr CNE (Figure 4.9), 
ecto-F0F1 complexes could be extracted only at 37
o
C, which is the temperature necessary to 
disrupt the environment of lipid rafts (Kim et al., 2006). Moreover, only the monomeric form 
of F0F1 was visible both at digitonin/protein ratios of 1 g/g and 2 g/g, with its extraction 
efficiency markedly dependent on digitonin concentration. Conversely, in mitochondria, 
extraction was optimal at 4
o
C, with little dependence on digitonin concentration.  The F0F1 
dimer was clearly visible in the mitochondrial extracts, with the monomer/dimer ratio 
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decreasing at increasing digitonin concentration as previously reported (Wittig et al., 2008). 
In contrast to the plasma membrane extraction, the efficiency of F0F1 extraction from 
mitochondria at 37
o
C markedly decreased compared to 4
o
C, although both monomers and 
dimers were still detectable in the extracts. Thus, the different extraction behavior of PMB 
and mitochondria made unlikely that the ecto-F0F1 complexes extracted from plasma 
membranes at 37
o
C raised from mitochondrial contamination.  
 
Figure 4.9 Detergent and temperature sensitivity of ectopic and mitochondrial F0F1 complexes. Plasma 
membrane and mitochondrial proteins (500 μg) were extracted using 1 g/g and 2 g/g digitonin at 4ᵒC and 37ᵒC. 
Detergent extracts (5 μl for mitochondria and 20 μl for plasma membrane) were separated by hr CNE followed 
by in-gel ATPase activity staining. Absolute band intensities were quantified and plotted against digitonin 
concentration. 
4.5 Localization of ecto-F0F1 complexes in plasma membranes of hepatocytes 
Although the role of ectopic ATPase in mediating HDL endocytosis is well 
documented (Martinez et al., 2003), its localization on the complex cell surface of 
hepatocytes is still to be defined. Hepatocytes, unlike many other cell types, are polar in 
nature (Figure 4.10). Apical poles from the front and adjacent sides where bile is secreted 
form a continuous network in contact with external media, while the basolateral side faces 
the portal blood and mediates uptake of blood components into the cell. It can be 
hypothesized that ecto-F0F1 complexes should be mainly localized on basolateral pole where 
they can mediate HDL endocytosis. To investigate this hypothesis, basolateral and apical 
membranes were prepared starting from PMB.  
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Figure 4.10 Pictorial representation of hepatocytes with apical and basolateral poles depicting the 
localization of ecto-F0F1 complexes on the basolateral side where it mediates the HDL endocytosis. 
Purity of both membranes were checked by denaturing electrophoresis followed by 
immunoblotting for respective markers, i.e. BSEP (bile salt export pump) for the apical and 
NTCP (sodium taurocholate pump) for the basolateral pole. Figure 4.11A shows a clear 
separation in markers between the separated membrane subfractions, indicating that the 
apical membranes had indeed been separated from the basolateral membranes. Both 
preparations were then subjected to detergent extraction and hr CNE followed by in-gel 
ATPase activity staining. Figure 4.11B clearly shows the enrichment in the ATPase activity 
of basolateral membranes as compared to the PMB preparation. Apical membranes show no 
ATPase activity (data not shown), indicating that ectopic complexes are solely localized to 
basolateral pole of hepatocytes. 
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Figure 4.11 ecto-F0F1 content of basolateral membranes. Basolateral and apical membranes were prepared 
from PMB as described in Methods. A. 40 μg of membrane proteins were separated on 12% SDS PAGE and 
immunoblotted against NTCP (basoalteral marker), BSEP (apical marker) and clathrin. B. hr CNE and in-gel 
ATPase staining of digitonin extracts of PMB and basolateral membranes. C. Histograms representing the ratio 
of markers to clathrin. 
4.6 hr CNE, in-gel activity staining and native immunoblotting of the respiratory chain 
complexes 
As discussed in the Introduction, subunits of ATP synthase were not the only proteins 
found at ectopic locations. Different research groups have demonstrated the presence of 
subunits of the four respiratory chain complexes in different cells by using 
immunofluorescence (Yonally and Capaldi, 2006), proteomic analyses of lipid raft 
preparations (Bae et al., 2004) or by checking their catalytic activity (Panfoli et al., 2009;  
Ravera et al., 2009), but  a definitive proof for their presence in the native state was still 
lacking. Here we endeavored to check the presence of these complexes in the native state by 
native electrophoresis, in-gel activity assay and immunoblotting using both PMA and PMB. 
Figure 4.12 depicts activity staining and native immunblotting of the complexes extracted 
from PMB. In case of complex III only native immunoblotting is shown as activity was not 
even sensitive for mitochondrial complexes. Complexes I and IV were found to be active and 
immunoreactive to their respective antibodies, showing that they are present in plasma 
membranes in native state, while complex II, which is a part of citric acid cycle, was not 
detected. Although a proteomic study has revealed complex II in lipid-raft preparations from 
other tissues (Bae et al., 2004),  its presence on cell surface has not been confirmed by 
confocal microscopy of osteosarcoma cells (Yonally and Capaldi, 2006).  The same analyses 
Results 
 
72 
 
performed using extracts from PMA showed a complete absence of all the complexes (data 
not shown).  
 
Figure 4.12 hr CNE, in-gel activity assay (C I, II and IV) and native immunoblotting of ectopic complexes 
extracted from plasma membranes prepared by method B (PM B) and mitochondria. Plasma membrane 
and mitochondrial proteins (500 μg) were extracted using 1 g/g of Digitonin at 37ᵒC and 4ᵒC, respectively. 
Extracts were loaded (5 μl for mitochondria and 20 μl for plasma membranes) on hr CNE and subjected to both 
in-gel ATPase activity staining and immunoblotting against in-house generated polyAb against the subunits of 
respiratory complexes.  
To characterize in more detail PMA and PMB for their content of plasma membrane and 
mitochondrial proteins in origin, denaturing electrophoresis and immunoblotting was 
performed. Among plasma membrane proteins, flotillin, a marker of lipid rafts, NTCP and 
bilitranslocase, which are markers of liver plasma membranes, were analyzed. Consistent 
with the hr CNE results, denaturing electrophoresis and immunoblotting confirmed the 
higher content of α/β subunits in PMB as compared to PMA, in spite of a similar content of 
flotillin which indicates the presence of lipid rafts in both the preparations (Figure 4.13). By 
comparing the levels of F1 α/β subunits, we calculated the levels of ecto-F1 in PMA and PMB 
to be about 3 and 6% of the levels observed in mitochondrial membranes, respectively. These 
values are consistent with those already reported (Giorgio et al., 2010).  On further 
investigation of other mitochondrial components, TOM 20, an outer mitochondrial 
B B B B B B B 
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membrane protein, was absent in both preparations, as well as complex II, being this latter 
consistent with the results obtained with the native electrophoresis (Figure 4.12). Conversely 
VDAC was found both in PMA and PMB, in accordance with previous reports (Bae et al., 
2004). Moreover, subunits of the other respiratory complexes were detected in both 
preparations, in spite of absence of functional complexes in native gel from PMA. Both 
preparations contained a similar amount of complex III and IV while they differred in the 
content of complex I subunit which was much higher in PMB as compared to PMA. Such 
pattern indicated that only method B preserved functional complexes.  
 
Figure 4.13 Western blotting of plasma membranes prepared from method A (PMA) and B (PMB) and of 
mitochondria. Mitochondrial proteins (5 μg) and plasma membrane proteins (40 μg) were separated on 12% 
SDS PAGE, transferred to nitrocellulose membrane and analyzed with indicated antibodies. 
4.7 Mass spectrometric analyses of ectopic F0F1 ATP synthase 
          The experiments by hr CNE of plasma membranes clearly demonstrated that ecto-F0F1 
complexes have a similar molecular mass to that of mitochondrial complex. But still the 
exact subunit composition of the ecto-F0F1 complexes was unknown. Besides that the 
absence of mitochondrial encoded subunits a and A6L couldn’t be figured out based on hr 
CNE due to their low molecular weight and hence making it almost difficult to discriminate 
the complete F0F1 complexes from those lacking these subunits. This was a critical point, still 
not clarified in literature (Vantourout et al., 2010), because detection of subunits a and A6L 
in the ectopic complex made its assembly on the plasma membranes unlikely, as it is unlikely 
that these subunits are targeted both to the cell surface and to mitochondria.  To clarify this, 
MS/MS  analysis  of the  hr  CNE gel bands containing F0F1  complexes  extracted from 
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mitochondria and PMB was performed,  to determine their subunit composition with special 
focus on the mitochondrial encoded subunits a and A6L, which also represented a 
methodological challenge due to their hydrophobic nature (Wittig et al., 2010).  
         By using a LTQ-Orbitrap XL mass spectrometer (ThermoFisher Scientific) coupled 
with an online nano-HPLC Ultimate 3000 (Dionex, ThermoFisher) both subunit a and A6L 
were identified with high sequence coverage in the bands obtained from mitochondrial 
membranes, along with all the F1 subunits (α, β, γ, δ and ε) and the F0 subunits b, d and 
OSCP (Table 7)  In the samples of plasma membranes, besides the majority of the F1 
subunits (α, β, γ, δ) and the F0 proteins b, d and OSCP,  subunit A6L was also identified 
(Table 8).  This finding supports the hypothesis that the ectopic complexes are first 
assembled in mitochondria and then shuttled to cell surface, most probably  by vesicular 
transport as recently proposed (Vantourout et al., 2010). 
Interestingly, MS/MS analyses revealed the presence of the adenine nucleotide carrier both in 
mitochondrial and plasma membrane F0F1 complexes, suggesting the maintenance of its role 
in both cellular compartments.  The identified proteins were subdivided into four classes 
according to (Bae et al., 2004): 1) proteins of plasma membranes or proteins already known 
to be localized in plasma membranes in spite of their alternative localization in other cellular 
organelles, 2) mitochondrial proteins, 3) proteins of endoplasmic reticulum and 4) other 
proteins (Figure 4.14). In this way the functional categorization of proteins appeared quite 
different for mitochondrial and plasma membrane samples, thus suggesting a low cross-
contamination of membranes between the two kind of samples.  
Results 
 
75 
 
 
Figure 4.14 Pie charts depicting the functional categorization of the proteins identified by LC-MS/MS in 
the hr CNE bands containing the F0F1 complexes extracted from mitochondria and plasma membrane.  
Proteins were categorized depending on their cellular localization. 
Sector Subunit MW (Da) Accession no. Coverage (%)
b
 
MS/MS 
peptides
c
 
F1 
α 56318 P10719 56.2 33 
β 59831 P15999 38.9 16 
γ 30229 P35435 40.3 10 
δ 17584 P35434 13.7 2 
ε 5820 P29418 15.7 1d 
F0 
a 25034 P05504 4.4 1
d
 
b 28965 P19511 36.3 13 
OSCP 23440 Q06647 41.8 8 
d 18809 P31399 37.9 7 
ATP8/ A6L 7637 P11608 46.3 3 
Carrier ADT2 33108 Q09073 34.6 10 
Table 7 List of the proteins identified by LC-MS/MS
a
 in the hr CNE bands containing the F0F1 complexes 
extracted from mitochondria. F0F1 bands were excised, destained with 10% acetic acid and subjected to mass 
spectrometry analysis as described in methods. 
a
The identified proteins with their accession numbers and molecular weights are listed. Protein identification 
was performed with the MASCOT software searching LC-MS/MS data against the sequences Rattus norvegius 
of the swiss prot database. 
b
Sequence coverage calculated on the basis of the peptides sequenced by LC-
MS/MS. 
c
Peptides sequenced by LC-MS/MS that matched to the protein with a significant score above the 
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threshold of identity or extensive homology (FDR < 1%). 
d
The MS/MS spectra of these peptides have a 
statistically significant score (P<0.05) and were manually validated.  
Table 8 List of the proteins identified by LC-MS/MS
a
 in the hr CNE gel bands containing the F0F1 
complexes extracted from plasma membranes prepared by method B.  
a
The identified proteins with their accession numbers and molecular weights are listed. Protein identification 
was performed with the MASCOT software searching LC-MS/MS data against the sequences Rattus norvegius 
of the Swiss Prot Database. 
b
Sequence coverage calculated on the basis of the peptides sequenced by LC-
MS/MS. 
c
Peptides sequenced by LC-MS/MS that matched to the protein with a score above the threshold of 
identity or extensive homology (FDR < 1%). 
d
The MS/MS spectrum of this peptide has a statistically significant 
score (P<0.05) and it displays a pattern of y/b ions identical to the MS/MS spectrum acquired for the same 
peptide in the mitochondrial sample, albeit of lower intensity. 
 
4.8 Immuno-precipitation of ecto-F0F1 from PMB - speculating the role of TERA 
       A closer look at the mass analysis revealed the presence of significant quantities of AAA 
ATPase (Transitional endoplasmic reticulum ATPase, TERA) in the band containing F0F1 
complexes from plasma membranes (Table 8). This was further confirmed by the 
immunodetection of TERA in the bands of ectopic F0F1 complex in hr CNE (Fig. 4.15A). 
Conversely, TERA was hardly detected in the mitochondrial samples in spite of its role in 
mitochondrial morphology recently reported in yeast (Esaki and Ogura, 2012;  Wang et al., 
Sector Subunit MW (Da) Accession no. Coverage (%)
b
 
MS/MS 
peptides
c
 
F1 
β 56318 P10719 35.7 15 
α 59831 P15999 38.9 22 
γ 30229 P35435 27.5 7 
δ 17584 P35434 17.3 3 
F0 
b 28965 P19511 32.4 7 
OSCP 23440 Q06647 26.8 5 
d 18809 P31399 24.2 3 
ATP8/ A6L 7637 P11608 14.9 1
d
 
Carrier ADT2 33108 Q09073 27.5 8 
 TERA 89977 P46462 28.9 21 
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2004). TERA is a homohexameric complex involved in a myriad of cellular function 
including ER-associated protein degradation, and has several alternative localizations 
including the plasma membrane (Wang et al., 2011). The co-migration of TERA and ecto-
F0F1 in hr CNE could be due to their similar molecular mass, but could also suggest a 
structural association of the two complexes in plasma membranes. To test this hypothesis, 
TERA was subjected to co-immunoprecipitation with commercially available antibodies 
against F1α subunit, as well as against holo-F1F0. TERA was found to precipitate with anti 
F1α, and F1α with anti-TERA (Figure 4.15C), suggesting that F1 subunit α did associate with 
TERA and vice versa. On the other hand, TERA did not precipitate with antibodies against 
the whole ecto-F0F1 complex (Figure 4.15B). indicating that the two complexes are not 
stably associated in plasma membranes.  Thus, the co-immunoprecipitation of F1α subunit 
and TERA might be an artifact. Alternatively, it could be speculated that TERA might 
associate with the subunits individually, possibly as a mediator of degradation of ectopic 
ATP synthase subunits. However, further work is certainly necessary to clarify this important 
point. 
 
Figure 4.15 Immuno-precipitation of ecto-F0F1 complexes and of isolated  subunit from plasma 
membranes. A. Plasma membrane proteins (500 μg) were solubilized using 1 g/g digitonin and were subjected 
to hr CNE and native immunoblotting with mAb against β and polyAb against TERA. B. Plasma membrane 
proteins (500 μg) were solubilized using 1 g/g digitonin and immunoprecipitated using the Immunocapture kit 
MS501 (Abcam) or A-sepharose 4B-coupled polyAb against TERA as described in Methods. The 
immunoprecipitate was subjected to 12% SDS PAGE and analyzed by Western blotting with mAb against α and 
with polyAb against TERA. C. α subunit or TERA was immunoprecipitated from plasma membranes using 
protein G-sepharose Fast flow coupled mAb against α subunit or  sepharose 4B-coupled polyAb against TERA 
as described in Methods and the immunoprecipitates were probed against α subunit and TERA. 
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       As reported in literature, TERA is an ATPase (Latterich and Patel, 1998;  Zhang et al., 
1994). Hence there was a possibility that TERA might interfere with the in-gel ATPase assay 
of ecto-F0F1 complexes giving a false positive results. To completely exclude this possibility, 
hr CNE and in-gel ATPase assay was performed on Digitonin extracts of PMB and 
mitochondria with and without the presence of 1 mM NEM (N-ethylmaleimide), which is 
reported to be an inhibitor of TERA (Zhang et al., 1994). Figure 4.16 depicts that 1 mM 
NEM has no effect on the ATPase activity of F0F1 complexes from both mitochondria as well 
as plasma membranes indicating that the ATPase activity observed in case of plasma 
membranes is solely due to ecto-F0F1 ATPase and not due to TERA. 
 
Figure 4.16 hr CNE, in-gel ATPase assay of F0F1 complexes extracted from PMB and mitochondria with 
and without 1 mM NEM. 
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Objective B (Immunofluorescence study of ectopic F0F1 ATP synthase) 
The work on rat liver clearly demonstrated the presence of ectopic F0F1 ATP synthase 
which has the same molecular mass of mitochondrial enzyme as evidenced by hr CNE, 
immunoblotting and mass spectrometry. Immunofluorescence confocal studies were then 
performed to have a visual and in vivo proof that the mitochondrial proteins reside at the cell 
surface in the lipid rafts. Therefore the second aim of my thesis was to check co-localization 
of F0F1 subunits ( β, OSCP and inhibitor factor IF1 ) and flotillin, a lipid raft marker, on HeLa 
cells. Along with this the role of cholesterol in mediating the shuttling of β subunit and IF1 
from mitochondria to the cell surface was studied. 
4.9 Immunofluorescence of permeabilized and non permeabilized cells 
Immunofluorescence is a very powerful technique to visualize a protein by labeling it 
with antibody. To visualize a protein inside a cell, for example a mitochondrial protein, the 
cell has to be permeabilized so that the antibodies can enter inside the cell and bind to the 
targeted protein. Here 0.1% Triton in PBS was used to permeabilize HeLa cells and to 
visualize mitochondria by labeling with antibody anti F0F1ATP synthase β subunit, which is 
one of the most abundant mitochondrial proteins. Figure 4.17.1B shows a typical pattern of 
fluorescence from mitochondria of permeabilized HeLa cell labeled with anti β antibody (red 
fluorescence). On the contrary, when permeabilized HeLa cells were also labeled with anti 
Flotillin (Figure 4.17.1A), which is a lipid raft marker of plasma membranes (Brown and 
London, 1998;  Glebov et al., 2005), no fluorescence was observed except few puncta which 
represented the permeabilized/broken pieces of the plasma membrane. So based on this it 
was clear that, when cells were permeabilized, only intracellular proteins could be visualized 
but not those localized in plasma membranes.  
Conversely, to visualize proteins on plasma membrane, cells were not permeabilized, 
in order to maintain intact membranes. Figure 4.17.2 shows a typical pattern of 
immunofluorescence from a non-permeabilized cell. Green fluorescence (anti Flotillin) 
clearly marks the boundary of the cell and detection of red spots by anti β shows the presence 
of β subunit on plasma membrane. 
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Figure 4.17.1 Immunofluorescence of permeabilized HeLa cells. HeLa cells permeabilized using 0.1% 
Triton, labeled with antibodies against anti Flotillin (A) (marker of plasma membrane lipid raft) and anti F1β (B) 
(maker for mitochondria).  
 
Figure 4.17.2 Immunofluorescence of non-permeabilized HeLa cells. Non-permeabilized HeLa cells labeled 
with anti Flotillin (A) and anti F1β (B).  
The fluorescence observed from a non permeabilized cell can also be an artifact or 
just a complex interplay of FITC secondary antibodies (Alexa Fluor). To confirm that it was 
not the case, two different approaches were used. In one approach cells were labeled only 
with secondary antibodies viz. AF 555 and AF 488 (negative control) along with DAPI ,to 
label nucleus, and were imaged for fluorescence. As expected, no fluorescence was observed 
in either case as shown in Figure 4.18 which clearly explains that the fluorescence observed 
in Figure 4.17.1 and 4.17.2 is solely due to binding of secondary antibody to primary which 
was attached to the target protein.  
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Figure 4.18 HeLa cells labeled with secondary antibodies AF488 and AF555 as a negative control. HeLa 
cells were cultured on coverslips and incubated with FITC secondary antibodies viz. AF488 and AF555 and 
viewed under the Leica SP5 Confocal microscope at 40X magnification as specified in methods 
In the second approach HeLa cells were labeled with antibody against β catenin in both 
permeabilized and non permeabilized conditions. β catenin is a protein which is expressed 
both at cell surface as well as inside the cell and hence should give fluorescence in both 
conditions (Haisken et al., 1994;  Orsulic et al., 1999). As expected, antibody detected 
antigen at the cell surface as well as inside the cell showing fluorescence in both the cases 
(Figure 4.19).  
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Figure 4.19 Permeabilized and non permeabilized HeLa cells labeled with antibodies against β catenin as 
a positive control. HeLa cells were plated on coverslips and permeabilized using 0.1% Triton in PBS or left 
intact. Coverslips were incubated with monoclonal antibody β catenin (1:500) and counterstained with AF555 
after washing with PBS as specified in methods. Coverslips were mounted using DAPI as a mounting medium 
and then viewed under Leica SP5 confocal microscope at 40X magnification.  
4.10 Mitochondria exist in two different morphologies  
Mitochondria were traditionally depicted as cylindrical organelles floating freely in 
the cytoplasm (Ardail et al., 1990). Now their dynamic nature has been widely demonstrated 
(Rube and van der Bliek, 2004), so their shape may often change within the cell depending 
on the cell cycle and from one cell type to other (Rube and van der Bliek, 2004). 
Mitochondria often undergo frequent fusion with themselves and with other organelles such 
as ER or even fission (fragmentation) which are implicated in different pathological 
conditions (Osellame et al., 2012). According to the literature (Yonally and Capaldi, 2006), 
mitochondria in two different morphologies were observed; Figure 4.20A, where HeLa cells 
were labeled with anti β antibody targeted to the mitochondrial matrix, shows the reticulum 
P 
NP 
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spreading across the cytoplasm. Figure 4.20B shows the second form mitochondria arranged 
around the nucleus giving a perinuclear morphology.  
 
Figure 4.20 Mitochondria switch to two different morphologies. HeLa cells labeled with anti F1β antibody 
show (A) reticular morphology and (B) perinuclear mitochondrial morphology.  
In this latter type of morphology, a significant part of the cytosol is devoid of other 
organelles making it easier to distinguish ectopic F0F1 from the mitochondrial part (Yonally 
and Capaldi, 2006). However, since no synchronization of the cell cycle was obtained, both 
types of mitochondrial morphologies were seen and used for the confocal experiments. 
4.11 Subunits of F0F1 complex and IF1 are present at the cell surface 
F0F1 ATP synthase is a bi-functional enzyme able to sustain both synthesis and 
hydrolysis of ATP depending on conditions and whose activity is modulated by a low 
molecular weight protein IF1 (Faccenda and Campanella, 2012). As explained in the 
Introduction, this enzyme complex was strictly believed to be expressed inside the inner 
mitochondrial membrane but recent reports have shown that individual subunits are present 
on the cell surface of various cells, mediating different biological functions (Chi and Pizzo, 
2006;  Vantourout et al., 2010). Confocal microscopy was one of the most used techniques to 
study this unexpected localization.  
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Figure 4.21 Co-localisation of β subunit with OSCP in mitochondria and on the cell surface of HeLa cells. 
HeLa cells were grown on coverslips and permeabilized or left intact as described in methods. After blocking, 
cells were incubated overnight with a mixture of antibodies containing monoclonal anti β (1:500) and 
polyclonal OSCP (1:500). After overnight incubation cells were counterstained by FITC antibodies AF555 and 
AF488 and viewed under Leica SP5 at 40X magnification. Permeabilized and intact cells cells are shown in 
Panel A and  B), respectively.  
Figure 4.21B shows the labeling of intact cells with monoclonal antibody anti β and 
polyclonal antibody anti OSCP. Yellow puncta in the merged panel as well as in PDM 
channel, which only showed the co-localized area with the nucleus, clearly demonstrated 
their co-localization on the cell surface with a coefficient of 0.94 stating that 94% of OSCP 
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proteins was coupled with β subunits shedding the light on the existence of ‘mitochondria 
like system’ in plasma membranes. As a positive control (Figure 4.21A), staining in 
permeabilized cells with anti β and OSCP showed a characteristic staining of mitochondria.  
A similar experiment was conducted in parallel to check the presence of the inhibitor factor 
IF1 on the cell surface of HeLa cells. Figure 4.22A shows HeLa permeabilized cells labeled 
with antibodies against β subunit and IF1. The fluorescence was intracellular and localized to 
mitochondria as expected with a perfect co-localisation which was demonstrated by yellow 
patchy pattern in merged panels. When cells were left intact, a typical extracellular staining 
pattern was observed for both β subunit (red) and IF1 (green). Upon merging the two panels 
45% co-localization was observed stating that both proteins are co-localized on the cell 
surface of HeLa cells. In summary, both the experiments clearly showed that subunits of F0 
and F1 along with IF1 were ectopically expressed on the cell surface of HeLa cells, 
suggesting that the whole complex was localized in plasma membrane, in accordance with 
the previous proteomic studies. 
4.12 Subunits of F0F1 complexes and IF1 reside in plasma membrane lipid rafts of HeLa 
cells 
To check the presence of ecto-F0F1 complexes in lipid rafts two parallel experiments 
were performed, one using β subunit and another using IF1. In the first experiment HeLa cells 
were marked with anti β and anti flotillin antibodies, both in permeabilized (positive control) 
as well as in non permeailized conditions. When cells were permeabilized (Figure 4.23A), β 
antibody bound to F0F1 in mitochondria whose fluorescence (red) was wide spread. 
Conversely, no fluorescence was observed with anti flotillin antibody, except few green spots 
showing broken membrane pieces and no co-localization with β subunit was obtained. When 
cells were left intact (Figure 4.23B), anti flotillin antibody clearly marked the area of the cell 
surface and β subunit showed punctuate distribution over the entire cell surface almost 
similar to that of flotillin. When both images were overlapped (merge and PDM channels), 
yellow spots clearly demonstrated that both proteins were co-localized with a co-localization 
coefficient of 0.5 (50% co-localization). 
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Figure 4.22 Co-localisation of β subunit and IF1 in mitochondria and at the cell surface of HeLa cells. 
Permeabilized (Panel A) or non-permeabilize (Panel B) HeLa cells were incubated with a mixture of a 
monoclonal antibody against β subunit and a polyclonal antibody against IF1 in the ratio of 1:500 in blocking 
solution. After overnight incubation cells were counterstained with FITC antibodies AF555 and AF488 and 
viewed under Leica SP5 Confocal microscope under 40X magnification. Red fluorescence indicate β subunit, 
green fluorescence indicate IF1, merge shows the co-localization and PDM channel shows only the co-localized 
area.  
In another similar experiment, HeLa cells were labeled with anti IF1 and anti flotillin 
antibodies in both permeabilized (positive control) and non-permeabilized conditions. 
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Permeabilized cells gave a characteristic mitochondrial staining due to binding of IF1 
antibody in mitochondria whereas no fluorescence was observed in case of flotillin (Figure 
4.24A). When cell were left intact, anti flotillin gave a characteristic plasma membrane 
staining marking the cell area whereas IF1 antibody showed a punctuate distribution over the 
cell surface (Figure 4.24B). Upon overlapping both the images, yellow spots in the merged 
panel as well as in PDM channels clearly showed that both proteins were co-localized with a 
co-localization coefficient of 0.6 (60% co-localization). 
 
Figure 4.23 Co-localisation of β subunit and flotillin on the surface of HeLa cells. HeLa cells were cultured 
on coverslips as described in methods and permeabilized using 0.1% Triton (Panel A) or left non-permeabilized 
(Panel B). After blocking, cells were incubated overnight with a cocktail of monoclonal antibody against 
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subunit β (1:500) and polyclonal antibody against flotillin (1:500). After washing with PBS, cells were 
counterstained with FITC antibodies AF555 (green) and AF488 (red).  
 
Figure 4.24 Co-localisation of IF1 and flotillin on the cell surface of HeLa cells. HeLa cells were culture on 
coverslips and permeabilized using 0.1% Triton (Panel A) or left non-permeabilized (Panel B) as described in 
methods. After blocking, cells were incubated overnight with a cocktail of monoclonal antibody against IF1 
(1:500) and polyclonal antibody against flotillin (1:500) and finally counterstained with FITC antibodies AF555 
(green) and AF488 (red).  
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4.13 Extracellular ATP synthesis by ectopic F0F1 ATP synthase in HeLa cells  
The question whether ectopic F0F1 ATP synthase can synthesize ATP is very 
intriguing. The ATP synthesis by mitochondria takes place due to a strong proton gradient 
between the two sides of inner membrane which provides energy to drive the nano-motor 
(Rees et al., 2012). It is still not certain whether a proton motive force to drive the synthesis 
of ATP exists on the surface of plasma membrane. The first demonstration of extracellular 
ATP synthesis was done by Moser et al in 2001, utilizing Luciferin-Luciferase system to 
measure the synthesized ATP (Moser et al., 2001). After this study other independent works 
demonstrated the extracellular ATP synthesis in many different types of cells (Vantourout et 
al., 2010).  While in most of these experiments the extracellular ATP measurement was done 
in aliquots collected at different time intervals, here an in vivo method was set up using a 
custom build Luminometer. Hela cells were plated on coverslips and flushed with recording 
medium (RM) containing ADP and MgCl2 at 37ᵒC following which the base counts/sec were 
measured. Further, cells were perfused with RM supplemented with 20 mM potassium 
phosphate (Pi), 50 μM Luciferin with 6 μg of Luciferase and the counts were recorded until 
the luminescence decreased and the counts came to the basal level. Similar experiments were 
run with cells pre-treated with oligomycin (10 μg/ml) or anti β antibody (1:500). The whole 
experiment was repeated with 2 different populations of cells. In all the experiments the 
extracellular ATP synthesis was observed, followed by its fast disappearance (Figure 4.25). 
These peaks of ATP synthesis were inhibited by oligomycin or anti β antibody, indicating the 
involvement of ecto-F0F1 complexes. Anyway, this phenomenon is quite intriguing and needs 
further experiments. 
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Figure 4.25 Extracellular ATP synthesis in HeLa cells using bioluminescent Luciferin-Luciferase method. 
HeLa cells were grown on coverslips as described in Methods. Cells were pre-incubated with oligomycin 10 
μg/ml or with anti β antibody. Luminescence was measured in a custom-built luminometer made in 
collaboration with Cairn Research (Faversham, UK). Cells were flushed with a medium containing 200 μM 
ADP and 2 mM MgCl2 (Recording medium, RM) and the base counts/sec was recorded. Then cells were 
perfused with RM supplemented with 20 mM Pi (potassium phosphate), 50 μM Luciferin and 6 μg Luciferase 
following which the counts were measured using luminometer until the basal level was reached. 
4.14 Cholesterol loading mediates the translocation of β subunit and IF1 from 
mitochondria to cell surface 
As reported in literature, the expression level of ecto-F0F1 changes in various 
pathological conditions (Cortes-Hernandez et al., 2005). Moreover, some factors, such as 
cholesterol which up-regulates (Wang et al., 2006) and niacin which down-regulate (Zhang et 
al., 2008) β subunit, seem to play a role in the trafficking of the enzyme from mitochondria 
to plasma membrane. 
To address this issue, HeLa cells were loaded with cholesterol (20 μg/ml) for a period 
of 0-4 h following which immunofluorescence studies along with Western blotting analyses 
were performed. Figure 4.26 shows permeabilized HeLa cells, preloaded with cholesterol for 
0 h (control) and 4 h and labeled with anti β and anti IF1 antibodies. The amount of seed 
culture was adjusted so as to achieve a confluency of not more that 60-70% to get a good 
filed for imaging. Fluorescence at 0 h showed a typical mitochondrial pattern for both IF1 and 
β subunit but at 4 h the fluorescence substantially decreased in both cases indicating that 
there was a loss of proteins. Such decrease might be either due to protein degradation or that 
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the proteins were trafficked to some extra-mitochondrial location after cholesterol loading 
(Figure 4.26). On the contrary, when intact HeLa cells, pre-loaded with cholesterol, were 
labeled with anti IF1 and anti β antibodies, the fluorescence at 0 h showed very faint 
fluorescence with very few puncta depicting that both proteins were ectopically located 
(Figure 4.27). At 4 h the fluorescence substantially increased in both the cases indicating an 
increase in protein content at cell surface. 
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Figure 4.26 Immunofluorescent confocal microscopic analysis of the permeabilized HeLa cells pre-
incubated with cholesterol for 0 h and 4 h and labeled with anti β and anti IF1 antibodies. HeLa cells were 
plated on coverslip as described in methods, one day prior the experiment so as to achieve confluency of 60%. 
Cells were then pre-incubated with cholesterol (20 μg/ml) for 0 h and 4 h at 37ᵒC, 5% CO2 chamber and were 
permeabilized. After blocking, cells were incubated overnight with a mixture of anti β and anti IF1 in blocking 
solution. After washing with PBS cells were counterstained.  
The immunofluorescence experiments clearly showed that mitochondrial protein 
content of both β and IF1 decreased at 4 h and in the same time it increased at cell surface, 
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suggesting that both  and IF1 were trafficked from mitochondria to plasma membranes. To 
confirm the microscopy results, Western blotting was performed on the mitochondria and 
plasma membranes prepared from HeLa cells, loaded with cholesterol for 0, 2 and 4 h. After 
electrophoresis and protein transfer, membrane was immunoblotted against anti β, anti IF1 
and VDAC (loading control). Immuno-detected bands were quantified using Quantity one 
(BioRad), normalized to loading control band intensity and plotted against the time of 
cholesterol incubation. Figures 4.28A and B showed that IF1 and β subunit level decreased 
in mitochondria while increased in plasma membranes in a manner dependent on cholesterol 
incubation time. These results were consistent with those obtained from immunofluorescence 
studies. Moreover they showed that the increase in the ectopic IF1 was much more marked 
and faster than that of , suggesting that the ATPase activity of the ectopic complex was 
progressively inhibited in the presence of cholesterol. It could be hypothesized that this 
mechanism prevented depletion of ATP at the extracellular level.  
 
Results 
 
94 
 
 
Figure 4.27 Immunofluorescent confocal microscopic analysis of non-permeabilized HeLa cells pre-
incubated with cholesterol for 0 h and 4 h and labeled with anti β and anti IF1 antibodies. HeLa cells were 
plated on coverslip as described in section 2.5, one day prior the experiment so as to achieve confluency of 
60%. Cells were then pre-incubated with cholesterol (20 μg/ml) for 0 h and 4 h at 37ᵒC, 5% CO2 chamber as in 
methods and were left non-permeabilized. After blocking, cells were incubated overnight with a mixture of anti 
β and anti IF1 (1:500) in blocking solution. After washing with PBS cells were counterstained as explained in 
methods.  
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Figure 4.28 Immunoblotting analyses of plasma membrane and mitochondrial proteins from HeLa cells. 
HeLa cells were cultured in petridishes and were preincubated with cholesterol (20 μg/ml) for 0, 2 and 4 h. 
After washing the cells with ice cold PBS, mitochondria and plasma membranes were prepared. Proteins were 
separated on a 12% denaturing SDS PAGE (40 μg/lane) following which they were transferred to nitrocellulose 
membrane and incubated overnight with anti β (1:5000), anti IF1 (1:1000) and anti VDAC (1:1000) antibodies. 
The intensities of the bands were normalized to that of loading control and plotted with respect to time of 
cholesterol incubation.  
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5. Discussion 
Detergent extraction of mitochondrial and ectopic ATP synthase: technical problems 
The choice of a detergent able to preserve a native complex has been the first 
challenge of this work. First step has been to compare the extraction of ATP synthase starting 
from mitochondria of different tissues and animals by using three non ionic detergents: 
Triton-X100, which is the more efficient in raft disruption (Kim et al., 2006), as well as 
DDM and digitonin, which are milder and extract native mitochondrial enzymes (Wittig et 
al., 2008). As expected, the all three detergents were efficient in extracting active ATP 
synthase complexes (Figure 4.1,4.2) while digitonin was the more effective in extracting 
active ATP synthase dimers, which represent the physiological form of the enzyme (Wittig et 
al., 2008). Moreover, the mitochondrial complex was evidenced by both in gel activity and 
Comassie Blue staining of BNE and hr CNE, although, as shown in Figure 4.3, hr CNE 
allowed a more rapid and sensitive determination of in gel native staining due to the absence 
of Coomassie blue dye in sample and running buffers, in accordance with previous reports 
(Wittig et al., 2007). 
Preparation of rat liver plasma membranes 
To prepare rat liver plasma membranes the method previously experimented in Udine 
laboratory was chosen (Giorgio et al, 2010). This method (PMA), based on the classic sub 
cellular organelles fractionation, was very time spending and at the end the ecto-F0F1 
complexes were very variable in term of protein amount and activity. The extraction of ecto-
F0F1 with Triton-X100, DDM and digitonin confirmed the efficiency of digitonin in 
extracting and preserving also native ecto-F0F1 complexes (Figure 4.4). The attempt to 
identify with 2D electrophoresis (hr CNE followed by SDS-PAGE) and immunoblotting 
ecto-F0F1 complexes extracted from PMA was unsuccessful probably because of the low 
sensitivity of this method and the variable content of ecto-F0F1 in PMA (Figures 4.5 and 4.6). 
A new method, faster and based on the knowledge that the bigger sheets of plasma 
membranes collapse on nuclei fraction, was experimented. The plasma membranes then 
could be rapidly separated by isopycnic centrifugation of nuclear fraction using 2 M sucrose 
to obtain plasma membranes denoted as PMB (Harris et al., 2005). Comparison of the two 
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preparative methods by hr CNE clearly showed that isolation of plasma membranes with the 
method B gave the best results in term of recovery and specific activity of the ecto-F0F1 
complexes (Figure 4.7). Consistent with hr CNE results, denaturing electrophoresis followed 
by immunoblotting confirmed a higher content of F1 α/β subunits in PMB than in PMA 
(Figure 4.13).  By comparing the levels of F1 α/β subunits, the levels of ecto-F1 in PMA and 
PMB resulted to be about 3 and 6% of the levels observed in mitochondrial membranes, 
respectively. These values were consistent with those already reported (Giorgio et al., 2010). 
Moreover, when PMB were subjected to further gradient-separation, the content of ecto-F0F1 
complexes remained unaffected, limiting the possibility that they arise from mitochondrial 
contamination (Figure 4.8). To confirm  the data of Figure 4.8 and further exclude that the 
ecto-F0F1 complexes were due to mitochondrial contamination, the dependency to 
temperature of plasma membrane and mitochondrial F0F1 complexes to digitonin extraction 
was analysed (Figure 4.11).  The best temperature for ecto-F0F1 extraction was 37°C, while 
for the mitochondrial complexes it was 4°C. Such difference is consistent with the  
localization of the ectopic enzyme in lipid rafts, which require a high temperature for 
solubilization of intrinsic proteins (Kim et al., 2006).   
Importantly, hr CNE analyses showed that ecto-F0F1complexes have a similar 
molecular mass to the mitochondrial ATP synthase monomers. This is consistent with the 
role of ATP synthase dimers in mitochondria to help formation of cristae, which are not 
present on the cell surface (Velours et al., 2011). However, absence of dimer formation could 
also be attributed to the very low content of  ecto-F0F1 complexes in lipid rafts (Gorai et al., 
2012). 
In conclusion, the data presented in this thesis not only confirm the presence of 
complete and active ecto-F0F1 complexes in hepatocytes, but demonstrate also their 
localization on basolateral pole, as indicated by the parallel enrichment of basolateral 
membranes and ecto-F0F1 complexes (Figure 4.11). The basolateral membrane is exposed to 
portal blood and this location is consistent with the role of ecto-F0F1 complexes in mediating 
HDL endocytosis by ADP-dependent activation of the P2Y13 receptor. Unfortunately, direct 
histochemical observation of the enzyme located on the cell surface in tissue sections was 
still lacking, probably due to lability (Champagne et al., 2006) or inaccessibility of antigenic 
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F0F1 epitopes (Vantourout et al., 2008). The location demonstrated in this work is particularly 
relevant for ATPase function, which could be an important target of therapies aimed at 
raising HDL cholesterol levels in blood plasma. 
In order to deep analogies and differences among PMA and PMB the presence of all 
OXPHOS complexes in digitonin extracts of both preparations was analyzed. In fact, 
subunits of ecto-F0F1 are not the only proteins reported to be present at ectopic location. As 
an example, Yonally et al demonstrated the presence of four OXPHOS complexes on the 
surface of osteosarcoma cells where these proteins show a punctuate distribution owing to 
their localization in the lipid rafts (Yonally and Capaldi 2006). Native staining of hr CNE 
showed that enzymatically active complexes I, III and IV were present only in PMB (Figure 
4.9), while their respective separated subunits were present both in PMA and PMB extracts, 
as assessed by denaturating immunoblotting (figure 4.10). These data confirm the integrity of 
PMB and the importance of the plasma membrane preparation method to obtain active 
complexes. 
MS/MS analysis 
 The similar molecular mass of ecto-F0F1 and mitochondrial F0F1 complexes favor 
their possessing the same subunit composition, raising the question of whether whole 
complexes are routed to cell surface, or whether isolated subunits are assembled there. To 
better understand this, MS/MS analysis of the hr CNE gel bands was performed on both 
mitochondrial and ecto- F0F1 complexes. In mitochondria, many of the F0 and F1 subunits 
were detected including the mitochondrial encoded hydrophobic subunits a and A6L (Table 
7). In case of plasma membranes, subunits α, β, δ and γ from F1 and subunits b, d and OSCP 
from F0 were detected with significant high sequence coverage (Table 8). The most striking 
thing was the identification of mitochondrial encoded subunit A6L in plasma membrane. As 
this subunit has a mitochondrial targeted pre-sequence, it is unlikely that it can be routed at 
cell surface. In accordance with this view, till now none of the nuclear encoded subunits of 
F0F1 complex has been identified with a pre-sequence for plasma membranes and none of the 
assembly factors of ATP synthase has been detected in plasma membranes (Vantourout et al., 
2010).  
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These observations suggest that ATP synthase is assembled in inner mitochondrial 
membrane and somehow routed to cell surface. This transit mechanism, and its regulation, 
are still unknown, although different patho-physiological conditions are associated with 
changes in the ectopic expression of ATP synthase (Giorgio et al., 2010;  Lyly et al., 2008). 
An interesting hypothesis is that F0F1 complexes may reach the cell surface via vesicular 
transport, which is consistent with the recent finding that in synaptic membranes F1  chain 
is in part N-glycosylated suggesting its transit through the Golgi apparatus (Schmidt et al., 
2007). Moreover, considering that distinct mitochondrial-derived vesicles have been 
characterized, such a mechanism could explain the cell surface location of other selected 
mitochondrial proteins (Figure 4.9), e.g. three of four respiratory complexes and the adenine 
nucleotide transporter. The presence of this latter is interesting because it suggests the 
involvement of the mitochondrial transporter in nucleotide delivery to ecto-F0F1 complexes 
across the plasma membrane, where various nucleotide transporters characterized by specific 
functions have been discovered  (Vantourout et al., 2010).    
Cholesterol was reported to be one of those factors which up-regulates the expression 
of β subunit at the cell surface (Wang et al., 2006). To clarify this interesting aspect, 
immunofluorescence studies were performed on HeLa cells which are discussed in the latter 
section.  
An intriguing aspect is how the ectopic ATP synthase can achieve its unusual and 
unique orientation in plasma membrane, i.e. with the F1 sector facing outside the cell. 
However, till now, no data exist and no hypothesis has been advanced. 
Another question regarding the ectopic ATP synthase is related to its degradation 
pathways, which are still unknown. Returning the ectopic enzyme to mitochondria for 
degradation seems unlikely. Our MS/MS and immunoprecipitation experiments suggest that 
the AAA ATPase TERA, which is able to extract proteins from protein complexes or lipid 
membranes (Wang et al., 2004), may be involved, since it interacts with isolated F1  subunit 
in plasma membranes, but not in mitochondria (Figure 4.15). However, further details of this 
process remain to be explored. 
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Immunofluorescence studies of ecto-F0F1 complexes in HeLa cells 
Immunofluorescence studies were performed on the HeLa cells to check the presence 
of F0F1 subunits along with IF1 in the lipid rafts of HeLa cells. Dual antibody labeling 
approach in both permeabilized and non-permeabilized conditions was applied using 
antibodies against anti β, OSCP and IF1 and flotillin. Flotillin was preferred as lipid raft 
marker because other markers, such as FM4-64X (Mangiullo et al., 2008) or mAb CF6 
(Yonally and Capaldi, 2006) are less specific for raft locations (Kim et al., 2006). Possibility 
of artifact or false fluorescence at the cell surface was excluded using an antibody again β 
catenin, which is a protein present at both extra- and intracellular locations. In fact, in both 
permeabilized and non-permeabilized conditions fluorescence was observed at surface and 
inside cell (Figure 4.19).  
An important observation was the presence of two different morphological forms of 
mitochondria viz reticulum in which mitochondria spreads across the cytoplasm as 
exemplified in Figure 4.20A and another being perinuclear (Figure 4.20B) in which cytosol 
is devoid of most of its organelles. A similar observation was found in osteosarcoma cells 
(Yonally and Capaldi, 2006). 
When cells were permeabilized both β subunit (red) and OSCP (green) gave a 
characteristic fluorescence similar to mitochondria (Figure 4.21 A) and the merged images 
clearly showed that both proteins reside together in mitochondria. When cells were left 
intact, both the antibodies detect antigen at the cell surface, giving a punctuate fluorescence 
(Figure 4.21 B), and orange yellow spots in the merge image clearly indicated that β subunit 
and OSCP were co-localized at the cell surface of HeLa cells. This observation was very 
important being OSCP the last subunit to be assembled, at least in yeast (Wittig et al., 2010). 
β subunit and OSCP were previously detected at the cell surface of hepatocytes (Mangiullo et 
al., 2008) indicating that the ectopic localization of these components was not restricted to 
few cell lines. In a similar experiment, HeLa cells were dual labeled with antibodies against β 
subunit and IF1 (green) in both permeabilized and non-permeabilized conditions, 
demonstrating both β subunit and IF1 also co-localized at cell surface (Figures 4.22 A and B), 
in accordance with the findings of Burwick et al (Burwick et al., 2005) and Cortes et al who 
detected IF1 on the cell surface of endothelial cells (Cortés-Hernández et al., 2005). All these 
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experiments showed that these proteins reside together at the cell surface suggesting the 
existence of “small mitochondria like system” in plasma membrane. 
Definitive proof that these proteins reside in the plasma membrane lipid rafts of HeLa 
cells was obtained by two parallel experiments in which HeLa cells were dual labeled with 
antibodies against β subunit/flotillin and IF1/flotillin in both permeabilized and non-
permeabilized conditions (Figures 4.23 and 4.24). These results are consistent with the 
findings of other groups who demonstrated the presence of F0F1 complex in lipid rafts by 
proteomic studies (Vantourout et al., 2010). 
Whether ectopic F0F1 complex can synthesize ATP has been challenged on many 
aspects and is still under investigation. Various research groups found that the complex was 
catalytically active as well as sensitive to most commonly used ATP synthase inhibitors. In 
some cases even other respiratory chain complexes were found to be catalytically active 
(Panfoli et al., 2009;  Ravera et al., 2009). The experiments on HeLa cells here obtained 
using a custom build luminometer demonstrated extracellular ATP synthesis. Such synthesis 
was found sensitive to oligomycin, which inhibits both ectopic as well as mitochondrial ATP 
synthase, and to anti β antibody, which inhibits only cell surface ATP synthase (Figure 4.25). 
Still there are many arguments against this notion. First of all, it is questioned the existence 
of a proton motive force required by F0F1 complex to synthesize ATP. Secondly, when cell 
medium was supplemented with [
3
H] ADP and 
32
Pi only [
3
H] ATP and no dual labeled ATP 
was detected, indicating that free inorganic phosphate was not utilized during ATP synthesis. 
Such finding suggests that adenylate kinase and not ATP synthase was responsible of ATP 
formation (Vantourout et al., 2010). Synthase activity of ectopic F0F1 complex is a very 
important issue to be addressed and requires more novel techniques.  
How the F0F1 complex reaches the cell surface is still unknown. Based on the 
detection of subunit A6L in the plasma membranes of rat liver, we hypothesized that the 
complex was assembled in mitochondria and somehow routed to cell surface for which the 
definitive proof is still lacking. As discussed before in the introduction, there are many 
factors reported which can either up or down regulate the expression of ectopic F0F1 ATP 
synthase. One such factor is cholesterol which had been reported to up-regulate the 
expression of β subunit (Wang et al., 2006). Here by using cholesterol loading experiments 
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the relocation of not only β subunit but also IF1 to cell surface was demonstrated by 
immunofluorescence and Western blotting analyses (Figures 4.26, 4.27 and 4.28). An 
important point to be noted is that the ratio of IF1 to β subunit was not constant from 0 to 4 h, 
implying that the expression of IF1 at the cell surface increased much more and faster as 
compared to β subunit. The higher cell surface expression of IF1, which was also observed in 
cholestatic rats (Giorgio et al., 2009), can be attributed to its role in preventing ATP 
depletion at the cell surface (Burwick et al., 2005).  
In conclusion, the results reported in this thesis document the presence of ecto-F0F1 
complexes in lipid rafts as holo-enzymes with a similar molecular weight of mitochondrial 
complexes. The wide range of cell types found expressing ecto-F0F1 complexes suggest that 
the ectopic expression is a ubiquitous process.  Far to be solved the definition of the 
mechanism by which the complex is routed to cell surface as well as various factors affecting 
it. Considering that different cellular functions and important roles played by the ectopic F0F1 
in various diseases are being deciphered, this topic represents is a very interesting challenge 
for future research.  
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